Robert Gorter, MD, PhD – Curriculum vitae

Nobel Prize in 2011, the Nobel Prize for Medicine was awarded to Ralph Steinman as he was the very first person to describe dendritic cells. Dr. Gorter and his team, in collaboration with the Universities of Göttingen and Vienna, played a major role in developing dendritic cells and their clinical applications. Dr. Gorter conducted clinical research and applied successfully dendritic cells consequently in cancer patients since 2000.

Previous/current Positions:

1) Associate Clinical Professor of Internal Medicine, University of California San Francisco Medical School (UCSF) 1983-2013

2) Associate Clinical Professor of Family and Community Medicine, University of California San Francisco Medical School (UCSF) 1983-2018

3) Senior Lecturer and Faculty at San Francico State University (SFSU) 1984-present

4) Dean and Associate professor (Privatdozent) University Witten-Herdecke (Germany) 1993-present

5) Professor at the “Freie Universität Berlin” (Germany) with his own „Institute for Oncologic and Immunologic Research at the Freie Universität” 1993-2012

6) Visiting Professor University of St. Petersburg Pavlov Medical School, (Russia) 1994-present

7) Associate Professor Department of Pharmagnosy University of the Western Cape (UWC) in Cape Town, South-Africa 2002-2016

8) Visiting Professor, Witwatersrand University, Johannesburg (South-Africa) 2002-2016

9) Visiting Professor, University of Shanghai Medical School, China 2013-present (interrupted by the COVID-19 pandemic)

Education on Television since 1983, an estimated 695 television interviews, life talk shows (where patients could call in) on national and international channels in USA, Germany, the Netherlands, Italy, Spain, Portugal,Turkey, Egypt, Lebanon, Brazil, Argentina, China, India, etc. In collaboration with San Francisco State University, a post graduate, long duistance program on masters degree levels on Anthroposophic medicine, the Gorter Model and the medical use of Viscum album (mistletoe) and Cannabis sativa (Hemp). Included were online lectures in a virtual auditorium and residential seminars around the world.

On September 13^th, 2023, Dr. Gorter gave an one-hour presentation about the Gorter Model for Beyaz TV; one of the three mjor TV stations in Turkey. Aproximately 2 million Turkish speaking viewers watch the program.

Languages Fluent in speaking and writing: Dutch, English, German, French, Afrikaans. Basic understanding of Italian, Portuguese and Spanish.

Citizenship the Netherlands; permanent resident USA and the EU at large; India.

Education & Degrees Primary and secondary (classical lyceum) education at the Coornhert Lyceum in Haarlem, Netherlands (Arbitur / Graduation “cum laude”)

1965-1971 State University of Amsterdam, Netherlands

Masters in Philosophy (MS)

Doctor of Medicine (MD, PhD)

1971-1973 Specialty Training in Family & Community Medicine at the State University of Amsterdam, Netherlands.

1973-1974 Tropical Medicine (infectious diseases) at the University of Amsterdam. This included half-a-year Surgery and half-a-year Gynecology and Obstetrics (urgent care).

Professional Training

1971-1973 Residency in Family and Community Medicine State University of Amsterdam

1973-1974 A further term of 6 months was spent in a teaching hospital in Basel, Switzerland, specializing in Oncology

1973-1982 School doctor Geert Groote (Waldorf) School in Amsterdam, the Netherlands, with 3,500 students.

1984-1987 Specialty training in General Internal Medicine, in Oncology, in Family & Community Medicine, in chronic viral infections including HIV, HBV, HCV, HPV, etc. and in Public Health at San Francisco General Hospital / University of California, San Francisco (UCSF) and Berkeley (UC Berkeley). Additional training in Epidemiology and Biostatistics (UC Berkeley)

Licensure

1971-present The Netherlands, Germany and all other countries of the European Union.

1978 License for Acupuncture (EU and California)

1984-2018 Medical License California, USA

1994-present Approbation, (Medical License), Germany

2005 Transfusionsverantwortlicher/-beauftragter transfusion and tissue specialist / Ärztekammer NordRhein in Düsseldorf, Germany / Medical Association.

1996 State Certification for Naturual Medicine; Zusatzbezeichnis für Naturheikunde Germany

1999 State Certification for Anthroposophic Medicine; Zusatzbezeichnis für Anthroposophische Medizin

Past Positions

1975 – 1984 Clinical Instructor, University of Amsterdam Department of Family Medicine (Huisartsen-geneeskunde)

1986 – 1988 Clinical Instructor, Department of Medicine University of California San Francisco

1987 – 1993 Attending Physican

Department of Medicine, San Francisco General Hospital

1988 – 1993 Associate Clinical Professor

Department of Medicine, Department for AIDS & AIDS Oncology, University of California San Francisco

1988 – 1992 Associate Clinical Professor

Department of Family & Community Medicine

University of California San Francisco

1986 – 1993 Medical Director

Department of AIDS Epidemiology & Biostatistics

University of California San Francisco

1988 – 1992 Attending Physician

Ralph Davies Medical Center and Hospital, San Francisco (Teaching Hospital)

1988 – 1992 Attending Physician

Pacific Medical Center and Hospital, San Francisco (Teaching Hospital)

1988 – 1993 Member San Francisco County Community Consortium Scientific Advisory Committee

1988 – 1993 Member Core Faculty APEX Program

San Francisco General Hospital

1987 – 1993 Medical Consultant

California Medical Facilities at High Security Prisons California Correctional System, Vacaville, California

1986 – 1994 Elected Member Executive Board of the Community Consortium for HIV/AIDS Care and Research, San Francisco Bay Area

1992 – 1994 Executive Dean for Clinical Affairs,

University of Witten/Herdecke, Medical School, Germany

1993 – 2000 Founder and Director of the European Institute for Oncological and Immunological Research in Berlin, Germany.

2001 Founder and Director of the International Society for Oncological and Immunological Research in Cologne, Germany, and in several other countries.

2001-2015 Founder and Director Medical Center Cologne, an international clinic specialized in Oncology and Immunology (and HIV Infection), and chronic degenerative diseases.

2004 – 2005 Co-Founder and Medical Director of Dendrimun-Köln, Germany (a society for the advancement of research in dendritic cells and mesenchymal stem cells and the exploitation of a research-orented laboratory).

Present and/or Past Positions

1993 – 2015 Associate Clinical Professor

Department of Family & Community Medicine

University of California San Francisco.

1987 – 2012 Attenting Physician

Department of Family and Community Medicine,

San Francisco General Hospital.

1993 – 2005 Member, Scientific Advisory Board

Gemeinschaftskrankenhaus Herdecke (one of the teaching hospitals of the University Witten/Herdecke, Germany).

1992 – Present Privatdozent (Associate Professor) University of Witten/ Herdecke, Germany

1992 -1994 Executive Dean of the Medical Faculty of the University of Witten/Herdecke, Germany.

1993 – 2010 Director, International Institute for Oncological and Immunological Research, Amsterdam, Berlin, Florence, Johannesburg, Palma, San Francisco and St Petersburg. Headquarters at the Free University (Freie Universität) in Berlin-Dalem.

1994 – 1998 Elected Vice Chair, Society for Therapeutic Local Anesthesia (Neural therapy)

1993 – present Visiting Professor, Department of Family Practice, Pavlov Medical Institute / MAPS (post-graduate training program) St. Petersburg, Russia

1984 – present Senior Lecturer (Associate Professor), San Francisco State University (SFSU), California, USA

1996 – 2008 Associate Professor University of the Western Cape, School of Pharmacy, Cape Town, South Africa with emphasis on Pharmagnosy and isolation and clinical trials with various plant components.

1993 – 2001 Associate Professor, Free University of Berlin (Freie Universität Berlin), Germany.

1994 – 2001 Director of the European Society for Oncological and Immunological Research, Berlin, Cologne, Cape Town, St Petersburg.

2000 – 2016 Director Medical Center Cologne (MCC), Germany. The MCC is a clinic for internal medicine with an emphasis in oncology, immunology, tissue repair, degenerative diseases, and chronic viral infections like HBV & HCV, HIV and HPV.

09/2003 – 2008 Director, Long Distance Learning Program on Anthroposophic Health Studies on a Masters Degree level, offered by San Francisco State University, College of Extended Learning.

Additional Clinical Experience

1. Founder and Director, First European Methadone Detox- and Maintenance Program for heroin addicts in Amsterdam, the Netherlands, including a detox program with Cannabis sativa. The City of Amsterdam provided two Cannabis cigarets per day.
   

1972 – 1983 (Executive) Medical Director, Detoxification Program, Jellinik Clinic Amsterdam, Medical Center for Drug Addiction and Alcoholism

1974 – 1984 Founder, Private Practice and Day Care hospital “Ita Wegman Huis” in Amsterdam, Netherlands

1973 – 1983 Volunteering School Doctor at the Geert Groote School (Waldorf School) with 3.000+ students

1973 – 1983 In collaboration with Amnesty International and the State University of Leyden, the Netherlands, and supported by the Dutch government, treating tortured political refugees whom the Dutch government accepted as refugees, according to the Declaration of Human Rights by the United Nations and the Convention of Geneva

1975 – 1984 Under the auspices of two Dutch State Universities, post-graduate training of physicians in Family and Community Medicine

1977 – 1983 Founder of a clinic for heroin addicts; treatment included electro-stimulation (electro-acupuncture). About 1800 patients were treated “ColdTurkey” in four years. A grant of $3,000,000 for 5 years was rewarded by the City of Amsterdam for this purpose.

1983 – 1993 Co-founder and leading physician Coming Home Hospice, a hospice for homeless AIDS patients in San Francisco, California, USA

1983 – 1993 Attending Physician, AIDS/Oncology Clinic

San Francisco General Hospital, ward 86, San Francisco, California, USA.

1984 – 1987 Senior Resident, Family & Community Medicine

San Francisco General Hospital

1987 – 1993 Co-founder Ayuvedic Clinic for the treatment of HIV/AIDS patients in San Francisco

1987 – 1993 Attending Physician at the high-security prison Vacaville, California, and co-founder of an AIDS-ward and various HIV/AIDS services at this prison facility.

1992 – 1995 Attending Physician Communtiy Hospital Herdecke, University Witten/Herdecke, Germany

1994 – 2001 Attending Physician Moabit Hospital, Free University Berlin, Germany

2000 – 2016 Medical Director and attending physician, Medical Center Cologne, Germany

Research Experience

1978 – 1983 Research into the effects of electro-stimulation on the production of endorphins in cooperation with a special team of the medical faculty at the University of Amsterdam

1981 Invited lecturer and visiting scolar to China by the Chinese government and hospitals in Peking, Kwanzhoo and Shanghai. Exchanges clinical experiences on the effects of electro-stimulation in heroin addiction and anesthesia, and advised on research in animals models and clinical trials

1984 – 1985 Study of blood clotting abnormalities in AIDS patients, San Francisco General Hospital, University of California San Francisco, USA

1984 – 1993 Psychological studies in HIV/AIDS patients, University of California San Francisco, (Collaborators: J. Mandel, PhD, UCSF; G. F. Salomon, MD, UCLA; Lydia Temoshok, PhD, UCSF)

1986 – 1987 Efficacy of Paromomycin on E. histolytica and non-pathogenic amoebas.

1986 – 1989 Abnormalities in brainstem provocations in HIV positives and AIDS patients

1986 – 2014 Immunomodulating and anti-viral activities of Iscador (Viscum album) in HIV disease

1986 – 1989 Immunomodulating effects of Ditiocarb (Imuthiol) in HIV- disease

1986 – 1989 Anti-viral effects of Dextran sulfate in HIV-disease

1989 Immunomodulating and anti-viral activities of Lentinan

1989 – 1994 Prevalence and progression studies of HTLV-1 and HTLV-II in IVDU’s and blood recipients

1989 – 2002 Assisted suicide by medical doctors in San Francisco during the AIDS epidemic

1990 – 2016 Clinical efficacy of Dronabinol and Cannabis sativa in AIDS and cancer patients with anorexia and cachexia

1993 – 1994 Absorbtion of heavy metals through the skin and its effects on the immune system

1993 – 2000 Interaction of heart rate variability and respiratory rate variability through non-linear time sequences

1995 – 1999 Immunmodulating and anti-HPV activities of Iscador in women with cervixdysplasia. Principal investigator of an international and multicentered controlled clinical trial.

1995 – 2000 Clinical efficacy of Dronabinol and Cannabis sativa planta tota in MS patients (Free University of Amsterdam)

1995 – 2016 Clinical efficacy of THC & CBD and Cannabis sativa in epilepsy and Glioblastoma multiforme stage IV.

1997 – 1999 Clinical efficacy of seabuc oil in atopical dermatitis.

1997 – 2006 Possible psychological changes in chronic Cannabis users.

1997 – 2001 In vitro and ex vivo in vitro stimulation of PBMC’s by Viscum album (Iscador).

1997 – 2003 Effects of viscolectins and viscotoxins on homing of lymphocytes through in vivo microscopy; in collaboration with the Rudolf Virchow University in Berlin.

1998 – Present Development and clinical efficacy of autologous monocyte-derived dendritic cell therapy in patients with (solid) tumors.

2003 – 2010 Development and clinical trial to document clinical efficacy of CCR5-negative adult stemcell in HIV infection.

2003 – 2016 Development and production of autologous adult mesenchymal stem cells for tissue repair (Diabetes mellitus, MS, post myocard infarction, CVA, degenerative joint disease, HCV-associated liver cirrhosis, etc.)

Teaching Experience

1968- 1982 School of Nursing

University of Amsterdam

1971 – 1983 Teacher and School Doctor at the Geert Groote School (3.000+ students) for Anatomy, Development of one’s Personality and Comparison of various World Views (religions), the Development of Thinking over the last 2.500 years, etc.

1976 – 1983 Clinical Instructor / Assitant Professor

University of Amsterdam

1984 – 1993 School of Nursing / Nurse Practitioner Training

University of California, San Francisco

1987 – 1990 University of California San Francisco

Clinical Instructor

Department of Medicine

Department of Family and Community Medicine

1991 – 1993 University of California San Francisco

Assistant Clinical Professor

Department of Medicine

Department of Family and Community Medicine

1993 – 2000 University of Califronia San Francisco

Associate Clinical Professor

Department of Family and Community Medicine

1992 – 1994 Executive Dean at the University of Witten/ Herdecke, Germany

1993- 2016 Associate Professor at the Pavlov Medical Institute, Department for Family Practice / MAPS (post-graduate trainingprogram) St Petersburg, Russia

1993 – Present Privatdozent (Associate Professor) at the University Witten/ Herdecke, Germany

1993 – 2008 Co-Founder and Excecutive Dean and Principal Professor at the School of Art Therapy (Scuola di Luca), Florence, Italy

2006 – present Co-Founder and Principal Lecturer at the School of Art Therapy in Bologna, Italy.

1994 – 2000 Faculty Member as Senior Lecturer, Free University and Humboldt Universities, Berlin, Germany

1995 – 2014 Associate Professor, Department of Family Medicine, Post Graduate Program, Medical University of St. Petersburg

1996 – 2008 Professor, School of Pharmacy, University of the Western Cape, Cape Town, South Africa.

1998 – 2005 Visiting Professor, Technikon University, Johannesburg, South Africa

1998 – 2005 Witwatersrand University Johannesburg, School of Medicine and School of Pharmacy, Johannesburg, South Africa

1999 – 2014 Development of the Long Distance Learning Program for Anthroposophical Health Studies, San Francisco.

2000 – 2002 Guest Professor in Residence, Center for Theoretical Studies, Charles University, Prague, Czech Republic (Director Ivan Havel).

Awards

1968 – 1973 “Studiebeurs” Medical School Scolarship as a donation and awarded by the Dutch government ($50.000)

1976 – 1980 Grant by Dutch government to establish detoxification clinic for drug addicts ($3.000.000,00)

1981 – 1983 University of Amsterdam grant to study effect of electro-stimulating on the production of endorphins ($50.000,00)

1987 Universities of California San Francisco & Berkeley grant to study “Public and Institutional Responses to AIDS in Amsterdam” ($ 800,.000)

1990 University-wide AIDS Task Force “HIV and other STDs Among Homeless People in San Francisco” ($260.000)

1993 Phase I/II study on potential anti-HIV and immunomodulating activities of Viscum album ($ 320.000)

1994 – 1999 Grant ($ 900,000 per year) to head the Institute for Oncological and Immunological Reseach, Freie Univerität in Berlin

1995 Grant ($ 200.00) for a phase-II trial to study efficacy of Iscador in women with cervixdysplasia from the German and Swiss governments

1996 Bundesministerium für Forschung und Technik, Bonn. Grant ($ 200.000) to study efficacy of Iscador in women with cervixdisplasia

1997 Grant ($1.800.000) for two controlled clinical trials in HIV positives in South Africa

1998 Grant ($ 1,000,000) for a phase-III trial to study efficacy and anti-HPV activities of Iscador in women with persistant cervixdysplasia and carcinoma-in-situ.

2009 Grant ($ 15.000) for a phase II/III study with dendritic cells in patients with stage IV Glioblastoma multiforme.

Membership in Professional Organizations

1974 – Present International Federation of Anthroposophical Medical Associations

1974 – Present Nederlandse Vereniging van Anthroposofische Artsen (Dutch Anthroposophical Medical Association)

1974 – Present Medical Section at the Goetheanum, Dornach, Switzerland

1978 – 1983 Koninklijke Maatschappij ter Bevordering van de Geneeskunde (Dutch equivalent to AMA)

1984 – 2014 American Academy of Family Physicians (Diplomate)

1984 – 1994 Community Consortium San Francisco Bay Area

1985 – 2014 California Medical Association

1988 – 1995 San Francisco Medical Society

1988 – 2014 International AIDS Society

1992 – 2012 Deutsche Arbeitsgemeinschaft Niedergelassener Ärzte in der Versorgung HIV-Infizierter (DAGNÄ)

1992 – 2012 Deutsche AIDS-Gesellschaft

1993 – Present Gesellschaft Anthroposophischer Ärzte in Deutschland

1994 – 2005 Society for Therapeutic Local Anesthesia / neural therapy

1994 – 2015 Society for Biologic Defenses against Cancer

1994 – 2018 Deutsche Gesellschaft für Onkologie (German Society for Oncology)

1997 – 2014 American Medical Association (AMA)

2001 – Present Deutsche Gesellschaft für Hyperthermie (German Society for Hyperthermia)

2001 – Present Gesellschaft für Biologische Krebsabwehr (Society for Biological Anti-Cancer Defense)

2001 – Present European Society of Hyperthermic Oncology

2002 – Present American Society of Clinical Oncology (ASCO)

2003 – Present International Society for Hyperthermic Oncology (ESHO)

2003 – Present European Society for Applied Immunology (EGAI)

Service to Professional Publications as Peer Reviewer over the last 35 years:

– Reviewer for AIDS, an International Journal

– Reviewer for Journal of Acquired Immunodeficiency Syndromes

– Reviewer for Journal of the American Medical Association

– Reviewer for Journal of Family Practice

– Reviewer for International Journal of Ethnopharmacology

– Reviewer for the Journal of Alternative and Complementary Medicine

– Reviewer for Journal of Neurology

Recent and/ or Ongoing University and Community Service

– Volunteer for several non-profit organizations serving people living with AIDS (hospice, homeless shelters, meals on wheels, Nkosi Johnson Foundation, Amnesty International, etc.).

– Member, Search Committees for various positions at the University of California San Francisco, San Francisco State University, and University of Witten/ Herdecke (Germany, 1983-2015).

– Board Member and Consultant, Anthroposophic Community Hospital Havelhöhe, Berlin (Germany, 1993-2012).

– Amnesty International (since 1973), volunteering physician for victims of torture in Amsterdam, Berlin and Cologne. One mission was made to Greece to study the phenomenon of torture and how to have regular citizens turn into vicious tortures and murderers (the “Lucifer Effect”)

– Co-Founder/supporter of the Brazilian NGO “The Associação Comunitária Monte Azul (ACOMA)” that adopted and actively participates in restoration through sponsoring and practical assistance in three Favelas in the southern part of São Paulo

https://en.wikipedia.org/wiki/Associação_Comunitária_Monte_Azul

– Principal member of the NGO called SEKEM (Ancient Egyptian: ‘vitality from the sun’ or prana in Sanskrite) was founded in 1977 by a group of German scientists and sponsors with the Egyptian gynecologist and social entrepreneur Dr. Ibrahim Abouleish in order to bring about cultural renewal in Egypt on a sustainable basis, including anthroposophic medicine and bio-dynamic agriculture.

https://en.wikipedia.org/wiki/SEKEM

– Deutsche AIDS Hilfe, volunteering physician and leturer.

– Advisor to the City and County of San Francisco Taskforce on Prostitution.

– With Fiorenza De Angelis, Founding member of the School of Art Therapy “Scola di Luca”, which is carried by a non-profit, tax-exempt organization), Florence, Italy in 1993 (www.scuoladiluca.org). and Founding Member of the Art Therapy School “Stella Maris” in Bologna in 2006

(www.associazionestellamaris.it/chi-siamo.html)

– Founder and active member of several initiatives to form Community Based Agriculture (CSA) for organic and bio-dynamic agricuture in Northern Europe and the USA.

https://en.wikipedia.org/wiki/Community-supported_agriculture

– Founding member of the „International Society for Oncological and Immunological Reseach“ in Amsterdam, Berlin, Cape Town, Florence, Johannesburg, Prague, San Francico and St Petersburg with patient education and support groups.

– Founding member of the Arbeitsgemeinschaft Cannabis als Medizin (National Society for Research of the Medical Use of Cannabis).

– Founding member of the “Haus um die Schenkung”, an international non-profit, tax-exempt organization to establish a center for cultural and economical collaboration (“Third Sector”) in Berlin, Germany and with collaboration with the Embassy of the Netherlands ( www.HUS.org ).

– Founding member, Medical Center Cologne am Eduardus Krankenhaus at Custodistrasse 3-17 in 50679 Cologne, Germany (2006), Cairo, Egypt (2006) and Sachsenring 83 in 50677 Cologne, Germany (2011), Amsterdam, the Netherlands (2009), Istanbul, Turkey 2010)

– Founding member of MultiCultiGambia, a non-profit, tax-exempt organization and based in the Netherlands and the Gambia, which supports and makes available scholarships to high school students and students for higher education in the Gambia, West Africa (www.multicultigambia.org).

– Advisor to the Lebanese Government for the development of agricultural efforts to grow medicinal plants (including Cannabis sativa) and develop medications (“phyto-engeneering”) in the Bekka, an economically depressed region of Lebanon till today.

– Advisor to the Anti-Maffia Organization”Contro il Pizzo; Cambia i Consumi” in Siciliy, Italy (www.addiopizzo.org).

– Advisor to a consortium of several universities in Egypt (Cairo, Tanta, Alexandria) regarding clinical research with dendritic cells and stem cells in advanced HCV-associated liver cirrhosis.

– Volunteering physician for refugees to Germany and the EU at large from Syria, Iran, Pakistan, Iraq and Afghanistan (since spring 2015- summer 2023).

– Active member of the Non-Profit organization “Friends of Ektaparishad” in Germany and in the EU at large. (support for poor farmers in India against land grab) since 2012.

– GreenPeace / Millieu Defensie (active member since 1978 till present).

– Consultant to the Nova Institue in Cologne in Germany for research and development of Industrial Hemp into bio-degradable plastics, fibers, diesel and nutirional oils, and graphene (www.nova–institut.de/). And advisor how to implement Cannabinoids like THC and CBD in pharmaceurical development.

– Board Member of the Indian Industrial Hemp Association (IIHA), Delhi, India.

Advisor to the Governments of Germany (BfArM) and the Netherlands in the field of Cannabis and its Cannabinoids: both for medical appication and as a nutritional supplement as well as for recreational use. (since 1993)

As volunteering medical doctor for the Red Cross and for the City of Cologne (Health Department) and for the University of Cologne (2015-2022).

Invited as Visting Professor / Keynote Speaker at National and International Symposia and Conferences on an Academic Level

1. AIDS Action Committee of Massachusetts, “Therapeutic interventions in HIV Infection” Boston, June, 1986
   
2. TUFS University, Boston, Massachusetts, Department of Family Medicine, “Transmission and Treatment of HIV Infection” October, 1986.
   
3. University of Amsterdam, Department of Medicine, “Epidemiology and Treatment of HIV Infection and Opportunistic Infections” October, 1986.
   
4. American Association of Anthroposophical Physicians: “Possibel Treatment Options from an Anthropoosphic Point of View: Viscum album as an Unique Immunomodulator with Antiviral Properties”, New York, June, 1987.
   
5. Kaiser Permanente, Oakland/Hayward, “Treatment of Opportunistic Infections in HIV/AIDS” August, 1987.
   
6. University of Amsterdam, Department of Medicine, October, 1987.
   
7. Vth National Nicaragua Health Colloquium, “Epidemiology and Care of HIV/AIDS Patients” Managua, Nicaragua, November, 1987.
   
8. Netherlands Government and WHO, Amsterdam: “Prophylaxis of Opporutnistic Infections in HIV Infection” December, 1987.
   
9. AIDS Action Committee of Massachusetts, Boston, “Update on Current Epidemiologic Data and Treatment Options” May, 1988.
   
10. IVth International AIDS Conference, “Transmission of HIV and Efficacy of Education in the Illegal Drugs-Using Population” Stockholm, Sweden, June, 1988.
    
11. University of Amsterdam, Department of Medicine, June, 1988.
    
12. International Society for Oncology, Basel, Switzerland: “New Data on Anti-HIV Activities of Viscum album” September, 1988.
    
13. University of Amsterdam, Department of Medicine: “Management of HIV-Related Opportunistic Infections” Amtserdam, the Netherlands, September, 1988.
    
14. San Francisco State University, November, 1988.
    
15. Advanced Immune Discoveries Symposium, Los Angeles, February, 1989.
    
16. International Society for Oncology, Basel, Switzerland, March, 1989.
    
17. XXIth National Lesbian and Gay Health Conference and VIIth National AIDS Forum, San Francisco, April, 1989.
    
18. AIDS Grand Rounds, Department of Public Health, San Francisco, April, 1989.
    
19. Hospital Consortium of San Mateo County, San Mateo, California, USA: “Management of Pain and Anorexia/Cachexia in AIDS Patienrs,” April, 1989.
    
20. NIDA Technical Review Meeting, Rockville, Maryland, July, 1989.
    
21. Federal University of Rio de Janeiro, Brazil, October, 1989.
    
22. University of Bahia, Salvador, Brazil, October, 1989.
    
23. Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, October, 1989.
    
24. University of San Paulo, Brazil: “Update on Management of Toxoplasmosis in HIV Infection” October, 1989.
    
25. Department of Public Health, San Paulo, Brazil, October, 1989.
    
26. University of California, Fresno / Central Valley Consortium of Hospitals “Management of Pain and Anorxia & Cachexia in HIV/AIDS” Fresno, California, November 1989.
    
27. Technical Review Meeting, Bethesda Maryland, December 1989.
    
28. University of Buenos Aires, Argentina: “New Therapy Modalities in the Oncologic Practice” and “Transmission and Epidemiology of HIV Infection,”April 1990.
    
29. Federal University of Rio de Janeiro, Brazil, April 1990.
    
30. Department of Public Health San Paulo, Brazil, April 1990.
    
31. University of California, Fresno/Central Valley Consortium of Hospitals, Fresno, California: “Early Management and Therapy of Opportunistic Infections in HIV Infection” May 1990.
    
32. VIth International AIDS Conference, San Francisco, California June 1990.
    
33. Department of Public Health, San Luis Obispo, September, 1990.
    
34. AIDS Grand Rounds, Department of Public Health, San Francisco, October, 1990.
    
35. National anti-AIDS Committee of Spain, Madrid, Victoria, Bilbao, Zaragoza, November, 1990.
    
36. University of Bilbao, Bilbao, Spain, November, 1990.
    
37. National Conference on AIDS, Zaragoza, Spain, November, 1990.
    
38. University of Pavia, Italy: “Immunomodulation by Phytoproteins (Viscum album) in Cancer Patients” and “Dronabinol (THC) in the Management of Cancer-Related Anorexia and Cachexia,” November, 1990.
    
39. University of Milan, Italy: “Immunomodulation by Phytoproteins (Viscum album) in Cancer Patients” and “Dronabinol (THC) in the Management of Cancer-Related Anorexia and Cachexia,” November, 1990.
    
40. International Society for Oncology, Basel, Switzerland: “Update on Preclinical and Clinical Data on the Effects of Viscum album on TH1 Response of CD4+ Lymphocytes in Cancer and HIV/AIDS Patients” November, 1990.
    
41. Free University of Berlin, Germany: “Treatment of Chronic Pain and Anorexia/Cachexia in HIV Infection,” November, 1990.
    
42. University of Hamburg, Germany: “HIV Infection, Early Detection and Prevention of Opportunistic Infections,” November, 1990.
    
43. California State University, San Francisco, March, 1991.
    
44. University-wide AIDS Task Force, San Francisco, March, 1991.
    
45. University of Götheburg, Sweden, March 1991.
    
46. International Conference on AIDS Policies, Vitoria-Gasteiz, Spain, April, 1991.
    
47. University of Rome, Italy, June, 1991.
    
48. Ministry of Public Health, Zwolle, the Netherlands, November 1991.
    
49. University of Florence, Italy, November 1991.
    
50. St. Joseph’s Hospital, Paterson, NJ, December 1991.
    
51. University of Southern California, Los Angeles, California, December 1991.
    
52. Cedar’s Hospital, Los Angeles, California, February 1992.
    
53. St. Michael’s Hospital, Newark, New Jersey. February 1992.
    
54. Kaiser Permanente Hospital, Los Angeles, California. Febuary 1992.
    
55. IVth German Conference on AIDS, Wiesbaden, Germany, March 1992.
    
56. AIDS-Forum KIS, München, Germany, June 1992.
    
57. AIDS-Forum KIS, München, Germany, September 1992.
    
58. University of Petersburg, Russia, January 1993.
    
59. Deutsche AIDS-Hilfe Berlin, Germany, January 1993.
    
60. 3. Münchner AIDS-Tage, München, Germany, February 1993.
    
61. San Francisco State University, San Francisco, Februar 1993.
    
62. First Russian National Conference on AIDS, Petersburg, Russia, June 1993
    
63. IXth International Conference on AIDS, Berlin, Germany, June 1993.
    
64. San Francisco State University, San Francisco, California, June 1993.
    
65. Int. Conference on Neuroimmunology, Istanbul, Turkey, Sept. 1993
    
66. University of Padua, Dept. of Pediatrics, Padua, Italy, Oct. 1993
    
67. Deutsche AIDS-Hilfe, Annual Conference for HIV-infected Individuals, München, Germany, Oct 1993
    
68. San Francisco State University, San Francisco, Dec. 1993
    
69. AIDS-Hilfe Frankfurt, Universtät of Frankfurt, Frankfurt, Jan. 1994
    
70. Deutsche AIDS-Hilfe/ NATC-Causus, Berlin, Feb. 1994
    
71. University of St. Petersburg Medical School, Russia, May, 1994
    
72. 4. Münchner AIDS-Tage, München, Germany, June 1994
    
73. Deutsche AIDS-Hilfe, Annual Conference for HIV-Infected Individuals, Stuttgart, Germany, Sept. 1994
    
74. Ludwig-Maximillian-Universität, München, Sept. 1994
    
75. University of St. Petersburg Medical School, Russia, Oct. 1994
    
76. National Conference on Biologic Defenses agaginst Cancer, “Clinical Efficacy of Viscum album, and ist components in Cancer Patients” Baden-Baden, Germany, Oct. 1994
    
77. Witwatersrand University Johannesburg, South Africa, Feb. 1995
    
78. International Conference Bioresource Hemp, Frankfurt, Germany, March 1995
    
79. University of Padua, Padua, Italy, June 1995
    
80. University of Tomsk, Siberia, Russia, Sept. 1995
    
81. Arbeitskreis AIDS/ Niedergelassene Aerzte Berlin, Germany, Oct. 1995
    
82. Ludwig-Maximilians-Universität, München, Germany, Oct. 1995
    
83. Conference on Clinical Application of Cannabis sativa in Cancer and AIDS, Berlin, Oct. 1995
    
84. Witwatersrand University of Johannesburg, South Africa, Nov. 1995: “Three-Fold Man as a Basis for Understanding Health and Disease.”
    
85. University Cape Town, South Africa, Nov. 1995
    
86. VII International Symposium, Caring for Survivors of Torture, Cape Town, South Africa, Nov. 1995
    
87. Medica, Düsseldorf, Nov. 1995: „Viscum album in the Palliative care of the Oncologic Patient.“
    
88. AOK/ Stadt Esslingen, Germany, Dec. 1995: „Cannabis sativa in the Palliative care of Cancer Patients.“
    
89. University of Freiburg, Germany, Dec. 1995: “Cannabis sativa und Mistel in der Onkologie.”
    
90. 5. Münchner AIDS-Tage, München, Germany, Jan. 1996
    
91. University of Hannover, Jan. 1996
    
92. European Academy, Otzenhausen-Nonnweiler: “Viscum album in HIV infection: an update on current clinical trials”, Saarbrücken, Germany, Feb. 1996
    
93. First European Conference on Experimental AIDS Research Cannes, France, March 1996
    
94. Naturheiltage Berlin, Apr. 1996: „Viscum album in HIV Infection.“
    
95. University of Cape Town, South Africa: “ Viscum album as an example of anthroposophically-extended oncology”, August 22^nd, 1996
    
96. Witwatersrand University Johannesburg, South Africa, Sept. 7^th, 1996: Natural Progression of HIV/AIDS and its prevention.”
    
97. 6. Deutscher AIDS-Kongreß München, Germany, Oct. 7^th, 1996: “Home Care and the Buddy System in HIV/AIDS.“
    
98. Medica Düsseldorf, Germany, Nov. 1996: “Mistel als Immunmodulator in der Onkologie und chronischen, viralen Infektionen.”
    
99. Witwatersrand University Johannesburg, South Africa, Dec. 1996
    
100. University of Aachen, Germany, Jan. 21^st, 1997: “Protozae and Parasitic Superinfections in HIV/AIDS.”
     
101. San Francisco State University: Anthroposophically-Extended Medicine”, San Francisco, January 25^th – February 2^nd, 1997
     
102. Biofach – International Conference on Hemp ’97: “Cannabis sativa and its applications in Medicine, Nutrition and other areas of daily life”, Frankfurt, Germany March 1997
     
103. First Swiss Conference on Cannabis sativa: “Medical Use of Cannabis sativa L.” Dornach, Switzerland, March 1997
     
104. Third International Conference on Home and Community Care for Persons living with HIV/AIDS: “Palliative Care of the Terminally-Ill AIDS Patient” Amsterdam, Netherlands May 1997
     
105. International Symposium on the Cannabinoids; International Cannabinoid Research Society, Atlanta, June 1997
     
106. 6. Münchner AIDS-Tage, München, Germany, July 1997
     
107. 31^st National Medical conference Baden-Baden, Germany November 1997
     
108. Medica Düsseldorf, Germany November 1997
     
109. National Cancer Institute, Cairo, Egypt, Dec. 1997
     
110. Ein Shams University of Cairo Medical School, Cairo, Egypt, Dec. 1997
     
111. Deutsches Zentrum für Luft- und Raumfahrt, Bonn, Germany, Dec. 1997
     
112. Facharztkolloquium Gynaekologie University of Rostock, Germany, Jan. 1998
     
113. 9. Deutscher Schmerztag, Frankfurt, Germany, March 1998
     
114. Ärztekammer Schleswig-Holstein / Akademie für Medizinische Fortbildung, Bad Segeberg, Germany, March 1998
     
115. American-Italian Cancer Foundation, “Update Phase-III Studies with Viscum album in HIV/AIDS Patients” Roncegno, Italy, April 1998
     
116. University of Utrecht and Vrije Universiteit of Amsterdam: “Cannabis als Geneesmiddel” (“Medical use of Cannabis”), Amsterdam, Netherlands, April 1998
     
117. “Academical Medicine and Complementary Medicine in Oncology”, German Society for Oncology, Usedom, Germany, May 1998
     
118. Body-Mind Center, “Anthroposophical Medicine and the Clinical Efficacy of Iscador in Cancer Patients” Washington DC, USA, June 1998
     
119. 12^th World AIDS Conference, “Viscum album in HIV Infection: an update on two Phase-III trials” Geneva, Switzerland, July 1998
     
120. Deutsche AIDS Hilfe, Berlin, Germany, August 1998: “Prevention of HIV transmission.“
     
121. 8^th National Workshop DAGNÄ, Cologne Germany, September 1998: “Ozone in HAART resistant HIV Infection: Delay of Progresion over 9 years.”
     
122. Gyllenbergs Stiftelse / Gyllenberg Foundation, “Viscum album in the Oncological Practice: an Update on Current Clinical Studies” Helsinki, Finnland, Oct. 1998
     
123. International Congress on Medical Marijuana, Heinrich-Böll-Stiftung, Frank-furt, Germany, December 1998
     
124. Arbeitsgemeinschaft Cannabis als Medizin, Köln, Germany, December 1998
     
125. Association pour la Recherche et l’Etude de la Médecine Anthroposophique, Paris, France, February 1999
     
126. University of Tiflis, current research of Viscum album in Oncology, Georgia, March 1999
     
127. 9^th International Conference on Biological Cancer Defense Mechanisms, Heidelberg, Germany, May 1999
     
128. University of Jena, the Medical use of Cannabis in pain, Germany, May 1999
     
129. 7^th German AIDS Congress: “Use of Viscum album and Complementary Medicine and the combination with HAART in HIV infection, Essen, Germany, June 1999
     
130. Body-Mind Center: “Complementary Medicine in the Treatment of Cancer Patients”, Washington DC, June 1999
     
131. AAAS, Pacific Division, San Francisco, June 1999
     
132. Artemisia: “Anthroposophical Medicine and its Advances in Clinical Research: an Update”, Baltimore, June 1999
     
133. Drug Information Association (DIA), as the representative of the Dutch government: “The Dutch model of Soft Drugs as Recreational Drugs and the Prevention of Consumption of Hard Drugs”, Washington DC, June/July 1999
     
134. Joint British and German Pharmacological Societies Meeting, “Medical uses of Cannabis sativa”, Nottingham, Great Britain, July 1999
     
135. South-African Complementary Medicine Association (SACMA): “Clical trials with Viscum album in HIV infection”, Cape Town, South-Africa, August 1999.
     
136. 9^th German Workshop DAGNÄ, “Current treatment of HIV infection with HAART and Viscum album”, Cologne, Germany, Sept. 1999
     
137. Annual Meeting of the “Verein für Farbmeridiantherapie nach Christal Heidemann”, Presentation of results of a phase I/II study in Farbmeridiantherapy in asthma, hypertension and migraine patients, Badenweiler, Germany, October 25 – 26, 1999.
     
138. Norwegian Society for Oncological Research, “Complementary Therapies in the Treatment of Cancer”, Oslo, November 1999.
     
139. Gesellschaft für Biologische Krebsabwehr, „Medizinische Anwendungen von Cannabis“, Celle, Germany, May, 2000.
     
140. Drug Information Association (DIA), “Current Research with Viscum album in HIV and HCV Infection”, 36th annual meeting, San Diego, USA, June 2000.
     
141. Drug Information Association (DIA), “Medical Use of Cannabis sativa, and the Drug Policies of the Dutch Government”, 36^th annual meeting, San Diego, USA, June 2000.
     
142. International Cannabinoids Research Society (ICRS), annual meeting, Baltimore, USA, June 2000.
     
143. University of Verona, Department of Paedagogics: Threefoldness and the Understanding of Illness and Development in Childhood. August 25^th -28^th, 2000.
     
144. Belgian (Flemish) Parliament, questioned as an Expert Witness during the Public Hearing on the Medical Use of Cannabis, Brussels, Belgium, September 15th, 2000.
     
145. EXPO 2000, Medical Use of Cannabis, Presentation and Chair of an all-day podium discussion on current clinical research with Cannabinoids, Wolfsburg, Germany, September, 2000.
     
146. University of Stellenbosch, Tygerberg Hospital, Overview of Recent Research with Viscum album in HIV and HCV Infection of own research group and that of others, Stellenbosch, South-Africa, September, 2000.
     
147. Charles University, Center for Theoretical Studies, Prague: Limits of Scientific Knowledge; Theory of Knowledge, erkenntnistheoretische Ansaetze in der klinischen Forschung, Prague, Czech Republic, November 17th-19th, 2000.
     
148. Terza Conferenza Nazionale sui Problemi Connessi con la Diffusione delle Sostanze Stupefacenti e Psicotrope, Chair and Lecturer “Medical use of Cannabis”, Genova, Italy, November 28th–30th, 2000.
     
149. University of Milan, Department of Medicine: “Interaction between Nutrition and Immune Function; the Importance of Trace Elements and Vitamines for Immune Function”, Milan, Italy, February 2^nd-4^th, 2001.
     
150. University of St Petersburg, Department of Family Practice: Patient presentations in oncology in the general medical practice: a practical seminar on diagnostics and current treatment options. St Petersburg, Russia, May 29^th –June 8^th, 2001.
     
151. University of Milan, Deparment of Medicine: HIV infection and addiction: prevention and therapy. Milan, Italy, June 22nd-24th, 2001.
     
152. Technikon Johannesburg: Immune responses in the microcirculation after immunomodulation with glycoproteins of Viscum album. Johannesburg, South Africa, July 13th & 20th, 2001.
     
153. Witwatersrand University of Johannesburg, School of Pharmacy: Anthroposophical pharmacology and immunomodulation by mistletoe glycoproteins (ML-I-IV) and viscotoxins, Johannesburg, South Africa, July 26th, 2001.
     
154. University of Stellenbosch, Department of Medicine: Practical (bedside) teaching seminar on physical exam, diagnosis and therapy for senior medical students and residents. Tygerberg Hospital, Belville, South Africa, August 3rd, 2001.
     
155. University of Verona, Department of Paedagogics : Sense perception and physiology of the sense organs, in connection with child development. Verona, Italy, August 27th-30th, 2001.
     
156. Witwatersrand University Johannesburg, South Africa, Oct. 5&6, 2001 : « Viscum album and Cannabis sativa in the treatment of HIV/AIDS : promising outcome of current studies. »
     
157. Annual Conference of Family Practitioners : The Human Biography and the Individual development. St Petersburg, September 28th – October 2^nd, 2001.
     
158. International Society for Oncological and Immunological Research : Two-day seminar on the social aspects of money : « Denaro : Quello che Avreste sempre voluto sapere » Milan, October 5th – 7th, 2001.
     
159. Second Natinal Annual Conference AKODH : Quality Assurance in Documentation of Care of Oncological Patients in the Private Practice Setting. Berlin, October 13th – 14th, 2001.
     
160. Chair of a seminar on Oncology & Immunology, and the use of dendritic cells, thymus peptides, Selenium and other trace elements: a three-day seminar at the University of St Petersburg, Russia, October 21st – 23rd, 2001.
     
161. Lecturing at the Witwatersrand University of Johannesburg, School of Pharmacy, and the Technikon, from November 19th through December 18th, 2001. Main subjects were Oncology and Immunology.
     
162. Lecture on clinical results of dendritic cell therapy in 498 advanced cancer patients with solid tumors at the Free University of Amsterdam, January 14th, 2002.
     
163. Lecture tour on HIV infection (clinical and epidemiological updates) in Johannesburg, Cape Town, Durban and Pretoria, South Africa, from April 9th through April 23rd, 2002.
     
164. 11. Internationaler Kongress der Gesellschaft für Biologische Krebsabwehr (Society for Biological Cancer Defense) : Medical Use of Cannabis in Oncology. Heidelberg, Germany, May 3rd-5th, 2002.
     
165. 11. Internationaler Kongress der Gesellschaft für Biologische Krebsabwehr (Society for Biological Cancer Defense) : New Developments in the Clinical Application of Dendritic Cell Vaccination. Heidelberg, Germany, May 3rd-5th, 2002.
     
166. Seminar on Mental Illness & Health from an Anthroposophical Medical Prospective. Pavlov Medical Institute and Post Graduate Training (MAPS). May 29th through June 3rd, 2002, St Petersburg, Russia.
     
167. Regulation and Promotion of Botanicals (Herbal Drugs) in Alternative Systems of Medicine at the 38th Annual Meeting of the Drug & Information Association (DIA), Chigaco, USA, June 16th through 21st, 2002.
     
168. University of Verona, Department of Paedagogics: Seminar on Education and Problem Oriented and Problem Solving Teaching Skills. Verona, Italy, August 29th – September 2^nd, 2002.
     
169. University of Palma, Mallorca : Seminar on the medical us of Cannabis sativa L. in the oncological practice. Palma, Mallorca, Spain, September 4th, 2002.
     
170. Deutsche Pharmazeutische Gesellschaft 100. Jahrestagung : « Wirksamkeit und Bedenklichkeit von Phytopharmaka » Titel : « Praktische Anwendungen von Cannabis und Cannabinoiden » / German Society of Pharmacology 100th Annual Meeting : « Efficacy and Toxicity of Botanicals » Titel : « Pratical applications of Cannabis and Cannabinoids » Berlin, Germany, October 10th -12th, 2002.
     
171. Arbeitsgruppe Pharmazie Dortmund und Skt Johannes Krankenhaus: « Medizinische Anwendung von Cannabis sativa in der Onkologie und HIV/AIDS Infektion » Dortmund, 5. November 2002 / Colloquium Pharmaceutical Society Dortmund and St John’s Hospital : « Medical applications of Cannabis sativa in Oncology and HIV/AIDS Infection », Dortmund, November 5th, 2002.
     
172. Ärtzekammer Rheinland/Westfalen Köln : « Medizinische Anwendung von Cannabis sativa in der Onkologie, HIV-Infektion und Schmerz » Köln, 6. November 2002 / Medical Society Rheinland/Westfalen in Cologne, Germany « Medical applications of Cannabis sativa in Oncology, HIV Infection and pain » Cologne, November 6th, 2002.
     
173. Universität Munster und Deutsche Multiple Sklerose Gesellschaft : « Medizinische Anwendung von Dronabinol (Cannabis) in der Onkologie, Neurologie und Schmerzbehandlung » Osnabrück, 20. November 2002 / University Münster and German Multiple Sclerosis Society : « Medical applaications of Dronabinol (Cannabis) in Oncology, Neurology and Chronic Pain » Osnabrück, 20. November 2002.
     
174. Rudolf Steiner College : « New on-line methods for post-graduate training of teachers and health care professionals ». Sacramento, California, USA, February 6th, 2003.
     
175. Academy of Post-Graduate Training : « Psychoneuroimmunology : the Importance of Love and Forgiving in a human biography » Milan, Italy, February 23rd-24th, 2003.
     
176. University of Cape Town, Tygerberg Hospital : « The Human Biography and its Various Developmental Stages » Cape Town, South Africa, March 21st & 22nd, 2003.
     
177. Onko-Treff / University of Hamburg : « Die medizinische Anwendung von Cannabis sativa und Cannabinoide in der onkologischen Praxis » / « Use of Cannabis sativa and Cannabinoids in the oncological practice ». March 26th, 2003, Hamburg, Germany.
     
178. 1. Colloquium Dronabinol-Therapie Consensus Treffen : « Dronabinol in der Onkologie und HIV/AIDS » / « Dronabinol in the treatment of oncological patients and in HIV/AIDS ». May 9th, 2003, Frankfurt, Germany.
     
179. 39th Annual Meeting of the American Society of Clinical Oncology (ASCO): « Correlation between clinical response and expression of CD1a+, CD80+, CD11c+ and HLA-DR+ by monocyte-derived dendritic cells in healthy individuals and cancer patients ». Chicago, May 31st-June 4th, 2003.
     
180. Ärtzekammer Münster / Akademie für Ärtzliche Fortbildung : « Von der Droge zum Arzneimittel-Cannabis in der Medizin » / Medical Society Münster : « From Illegal Drug to Medication- Medical Use of Cannabis » Münster, Germany, June 18th, 2003.
     
181. San Francisco State University : « New Frontiers in Cancer Treatment : the Cologne Model » San Francisco, September 9th, 2003.
     
182. Symposium: Nieuwe Wegen in de Strijd tegen Kanker / « New ways in current cancer therapy » Scherpenzeel, the Netherlands, October 4th, 2003.
     
183. University of the Western Cape & University of Stellenbosch, Cape Town, South Africa: « The Development of Thinking over the Last 2,500 years in relation to Medical Paradigms » Cape Town, October 12th, 2003.
     
184. University of Padua (in collaboration with the City of Padua) ; « The role of fever and childhood diseases in the development of the immune system of the child » Padua, Italy, November 7th-9th, 2003.
     
185. University of Athens, guest speaker: « the Cologne Modell : a new and innovative approach in cancer therapy » December 5th & 6th, 2003, Athens, Greece.
     
186. San Francisco State University, public lecture: « Fever-Range Total-Body Hyperthermia in the Battle against Cancer », San Francisco, USA, February 3rd, 2004.
     
187. St Petersburg Medical Faculty, Post Graduate Training Program: « The Cologne Model : new approaches in the oncological practice », St Petersburg, Russia, March 12th through 15th, 2004.
     
188. City and University of Padua: « Latest Developments in the the Treatment of the Oncologic Patient with Autologic Dendritic Cells and other Immune Therapies », Padua, Italy, March 18th – 19th, 2004.
     
189. National Teachers Association Italy in collaboration with the University of Anthroposophic Studies: « Effects of Electro-Magnetic Fields and Radiation on the Development of the Immune System, and Immunologic Disorders, including Cancer » (« Tecnologia e Mondo Virtuale »), Milan, Italy, March 25th – 26th, 2004.
     
190. Scuola di Luca in collaboration with San Francisco State University, College of Extended Learning : « Therapeutic Effects of Etching in the Treatment of Addictive & Compulsive Behavior Disorders » Urbino, Italy, April 9th -12th, 2004.
     
191. The Kadota Fund International Forum 2004 : Applications of thermal stress for the improvement of health – Concensus and Proposals- Speaker and Chair of a half-day plenary session and podium discussion : « Fever-Range, Total-Body Hyperthermia in Combination with Autologous Dendritic cells in Cancer Patients » Awaji Yumebutai International Conference / Japan Health Foundation Kadota Fund & Hyogo International Association, June 14th – June 18th, 2004.
     
192. University of Antwerp, Department of Neuro Surgery: Seminar on the Introduction and Application of Autologous Monocyte-Derived Dendritic Cells in Primary Brain Tumors (co-speaker Dr. Thomas Nesselhut, Göttingen). July 9th, 2004, University of Antwerp, Department of Neuro Surgery, Antwerp, Belgium.
     
193. University of Ghent, Department of Infectious Diseases : « Dendritic Cell Vaccinations in Combination with Cannabis sativa
     
194. San Francisco Medical Society in collaboration with San Francisco State University : « New Frontiers in Cancer Research : autologous dendritic cells and New Castle Disease Virus as a promising oncolytic virus. » Lecture, September 13th, 2004, San Francisco State University.
     
195. University of Istanbul, Faculty of Medicine. “Novel Therapeutic Interventions in Cancer Therapy: Autologous Dendritic Cells, Hyperthermia and New Castle Disease Virus” Istanbul, Turkey, September 26^th, 2004.
     
196. Ciyt and County of Florence, Italy: “L’impatto della tecnologia e del mondo virtuale sull’equilibro interiore e sulla salute mentale” September 15th, 2004.
     
197. National Irish CSF/ME Trust: « Diagnosis and Treatment of CFS and ME in the Cologne Modell: Update of Clinical Data and Research » Dublin, Ireland, November 18th – 21st, 2004.
     
198. Dutch National Society for Integrative Medicine (ABNG-2:000) “Novel Anti-Cancer therapies: Hyperthermia, Dendritic Cells and New Castle Disease Virus” Ellecom, the Netherlands, November 26^th, 2004.
     
199. City and County of Florence in collaboration with the Medical School of the University of Florence, Department of Pediatrcs (Professor dr Roberto Salti), Italy: “Fattori ambientali, esposizione televisiva, anticipo della maturazione sessuale & Crescita fisica, psicologica, spirituale del bambino nella Scuola Waldorf” December 18^th, 2004.
     
200. Jan van Bremen Instituut (National Center for Rehabilitaion Psychology and Education), Amsterdam: “Fibromyalgia; causes, diagnosis and therapy” January 20^th, 2005. Amsterdam, the Netherlands.
     
201. San Francisco State University, as part of the serie “Establishing Excellence:” “Cancer as an Immunologic Illness: a Shift in Paradigms”. February 14^th, 2005. San Francisco, USA.
     
202. Cerranpasha University Medical School, Department of Medical Oncology: “Dendritic Cell Vaccination in Patients with Solid Tumors.” April 4^th, 2005, Istanbul, Turkey.
     
203. University of the Western Cape, School of Pharmacy: “Medical use of Cannabis” April 18^th, 2005, Cape Town, South Africa.
     
204. University of the Western Cape, School of Pharmacy: “Dendritic Cell Vaccination and Immune Restoration in Cancer Patients” April 19^th, 2005. Cape Town, South Africa.
     
205. Ministry of Health of the Republic of Yemen, Sana’a; April 30^th through May 7^th, 2005. Advisor to the Minister of Health to improve primary care services in Yemen and establish a formal Family Practice Program at the Medical School in Sana’a, and other universities.
     
206. Ärtzekammer (Medical Society) Wuppertal und Municipal Police: “Recreational Use of Cannabis and Potential Psychologic and Sociologic Damage in the Adolescent” Wuppertal, Germany, May 24^th, 2005.
     
207. Workshop Duderstadt-Göttingen: “Improvements in Immunotherapy in Regard to the Oncologic Patient” June 4^th, University Göttingen, 2005.
     
208. San Francisco State University: “Cancer therapies: Quo Vadis?” San Francisco, California, USA. September 13^th, 2005.
     
209. Public lecture: “Dendritic Cells, Hyperthermia and New Castle Disease Virus as New Options for the Treatment of the Oncologic Patient” National Foundation Against Cancer, Zutphen, the Netherlands. September 28^th, 2005.
     
210. Dutch National Foundation for Cancer Rsearch; Public Lecture for Primary Care Health Providers: “Psychologic Support of Cancer Patients and Update on Latest Studies in Psychoneuroimmunology” Heerhugowaard, the Netherlands, October 8^th, 2005.
     
211. City and County of Bologna: “Three-Fold Social Order in Relationship to Management of Schools and Educational Institutions”, Bologna, Italy, November 19^th, 2005.
     
212. University of Utrecht: “New Frontiers and Shifts in Paradigms in Scientific Research” Utrecht, the Netherlands, December 8^th, 2005.
     
213. Cerranpasha University of Istanbul, Medical School, Turkey: “Autologous, Monocyte-Derived Dendritic cells in the Oncologic Patient: an Update” Istanbul, Turkey, January 31^st, 2006.
     
214. Cerranpasha University of Istanbul, Medical School, Turkey: “New Look on Oncolytic Viruses as New Castle Disease Virus, Tanga- and Parvoviruses,” Istanbul, Turkey, February 1^st, 2006.
     
215. Gruppo Medico Antroposofico Siciliano / City of Palermo: “La Biographia Umana nei Primi ter Settenni” (Development of the Child in its First Three Septennuals, and its Effects on Later Life) March 17 & 18^th, 2006, Palermo, Italy.
     
216. University of Stellenbosch & Anthroposophic Society Western Cape: “The Immune System: understanding AIDS and opportunistic infections like TB, and HIV-related malignancies” April 2^nd through 9^th, 2006, Cape Town, South Africa.
     
217. Medical Society & Department of Psychology, University of the Western Cape & Anthroposophical Society Western Cape: “Human Rights, Civil Society, and Threefold Social Order” April 2^nd and April 9^th, 2006, Cape Town, South Africa.
     
218. University of the Western Cape: “the Medical Use of Cannabis and its derivitives” in HIV/AIDS, Oncology and Pain” Cape Town, South Africa, April 4^th & 5^th, 2006.
     
219. Cerranpasha University of Istanbul, Medical School, Turkey: “Update on new Developments on Clinical Studies with Dendritic Cells and Activated NK cells”, Istanbul, April 28^th, 2006.
     
220. American Association for Clinical Oncology (ASCO); oral presentation: “ Successful autologous stem cell application for tissue repair after complete remission of grade IV astrocytoma with seven autologous dendrititc cell vaccinations.” Atlanta, GA, USA, May 5^th, 2006.
     
221. San Francisco State University in collaboration with the International Society for Oncologic and Immunologic Research: “Highlights of the ASCO Conference (American Society for Clinical Oncology) in Atlanta, May 6^th – 10^th, 2006: Advances in Immune Therapy with Dendritic Cells and other Potent Immunogenic Cells in the Cancer Defense Mechanism” San Francisco, USA, May 11^th, 2006.
     
222. Cells for Life Foundation, Egyptian Chapter: ”New Developments in the Application of autologous Dendritic Cells and Stem Cells” Cairo, August 27^th, 2006.
     
223. University of Alexandria Medical School: “Clinical Application of Autologous Adult Stem Cells and Dendritic Cells” Alexandria, Egypt, October 15^th, 2006.
     
224. Biofeedback Society of California (32^nd Annual Conference): “Evidence-Based Mind/Body Medicine: Circadian Rhythms in Core Body Temperature in Cancer Patients and Healthy Individuals as Surrogate Marker for Prognosis and Outcome” San Francisco, November 3^rd through 5^th, 2006.
     
225. University of Alexandria Medical School: “Clinical Application of Adult Stem Cells in Regenerative Medicine and Dendritic Cells in the Oncological Patient”, Alexandria, Egypt, November 20^th, 2006.
     
226. American Society for Applied Psychophysiology and Biofeedback, 38^th Annual Conference, Monterey, California, USA: keynote speaker: “New Perspectives: Etiology and Treatment of Cancer” February 16^th, 2007.
     
227. San Francisco State University: “New Frontiers in the Application of Dendritic Cells and Adult stem Cells” San Francisco, California, USA, February 19^th, 2007.
     
228. 11^th Annual BFE Meeting, University of Applied Sciences (Technische Fachhochschule): New Frontiers in Oncology: Hyperthermia and Circadian Rhythms of Core Body Temperature as a Surrogate Marker for Outcome of Clinical Interventions, Berlin, Germany, March 1^st, 2007.
     
229. 2^nd International Workshop in Biotechnology under the Framework of the German-Egyptian Year of Science and Technology and the Pharos University in Alexandria: “New Frontiers in Clinical Applications of Adult Stem Cells and Dendritic Cells” Alexandria, Egypt, March 14^th, 2007.
     
230. 12^th Annual Conference of the European BioFeedBack Foundation & University of Salzburg: “Circadian Rhythmy in Core Body Temperature in Cancer Patients and Healthy Volunteers, and its Prognostic Value in Cancer Treatment” Salzburg, Austria, February 20^th, 2008.
     
231. University of Alexandria, Key Note Speaker: “Applied Cell Therapy: Dendritic Cells in the Oncologic Patient and Adult Stem Cells in Tissue Repair” Alexandria, Egypt, June 14^th, 2008. (lecture was not delivered due to sudden changes in program and missed air plane connections).
     
232. San Francisco State University: “Non-Toxic Treatments like Dendritic Cell Vaccinations and Hyperthermia in the Oncologic Practice” November 3^rd, 2008 San Francisco, California, USA.
     
233. State University of Bologna, Italy, Depertment of Medicine, after the annual congress of the International Society of Immune Therapy in Oncology, Orlando, Florida, October 2008: “Dendritic cell vaccinations in the oncologic patient: an update.” Bologna, Italy, December 18^th, 2008.
     
234. San Francisco Sate University in collaboration with the Medical Society San Francisco, California: Adult Stem Cell Application in Chronic Degenerative Disease” March 19^th, 2009, San Francisco, California, USA.
     
235. Medical Section at the Goetheranum Hochschule in Dornach (Basel), Switzerland; Annual International Medical Conference: “Dendritic Cell Vaccinations in Cancer and Chronic HCV Infection” Dornach (Basel), Switzerland, September 18^th and 19^th, 2009.
     
236. University of Tanta, Egypt, Invited Lecturer: “Dendritic Cell Vaccination in the Oncologiy Patient” Tanta, Egypt, December 10^th, 2009.
     
237. Ain Shams University Cairo, Egypt, key note speaker at conference on Stem Cells: “Clinical Applications of Mesenchymal Stem Cells in Chronic Disease: Morbus Parkinson and HCV-Associated Severe Liver Cirrhosis” Cairo, Egypt, December 12^th, 2009.
     
238. Egyptian Society for Progenitor Cell Research (ESPCR) Second International Congress of Progenitor Cell Research, Cairo, Key Note Speaker: “Stem Cell Types: an Introduction in respect to ethical considerations” and “Stem Cells and Dendritic Cells in End-Stage HCV-associated Liver Cirrhosis” Cairo, Egypt, June 12^th and 13^th, 2010.
     
239. Lecture series on “Dendritic Cell Vaccinations in Glioblastoma multiforme stage IV and other High Grade Gliomas” and “Dendritic Cell Vaccinations in Advanced HCV-Associated Liver Cirrhosis in Combination with Adult Stem Cells”, University of Zigazic, Egypt, July, August and September 2010.
     
240. “Update on the Clinical Use of Dendritic Cells in Combination with Mesenchymal Stem Cells in Patients with Advanced HCV-associated Liver Cirrhosis” Anthroposophical Medical Association of Russia, Moscow; October 14^th, 2010.
     
241. “The Gorter Model: an Innovative Non-Toxic Approach to Cancer with dendritic Cells in Combination with Hyperthermia” Anthroposophical Medical Association of Russia, St Petersburg, in cooperation with the Medical school of St. Petersburg (Pavlov Institute), October 15^th, 2010.
     
242. “Non-Toxic Cancer Treatment” by Gaia Medicine, The Kadota Fund International Forum 2011, and the University of Kyoto, Faculty of Medicine, Kyoto, Japan, February 12^th, 2011.
     
243. “The Gorter Model: Non-Toxic Treatments in Cancer” Rajev Gandhi Cancer Research Institute and Hospital, Delhi, India, May 8^th, 2012.
     
244. “The Gorter Model: a Non-Toxic Treatment in Cancer” Delhi State Cancer Research Institute and Hospital, Delhi, India, May 9^th, 2012.
     
245. “Possible Efficacy of Dendritic Cells in Patients with Solid Tumors” National Institute of Pathology, Delhi, September 24^th, 2012.
     
246. “The Use of Dendritic Cells in Combination with Mesenchymal Stem Cells in Patients with End-Stage Hepatitis C Associated Liver Cirrhosis” Delhi State Cancer Institute and Hospital, Delhi, India September 27^th, 2012.
     
247. “The Application of Adult Autologous Mesenchymal Stem Cells in Neurological Damage and Childhood Autism and Dendritic Cells in recurrent Glioblastome miltiforme stage IV” at the Vidyasagar Institute of Mental Health and Neurosciences; Delhi, India, December 22^nd, 2012.
     
248. With MD Anderson Cancer Center in Texas, USA, a joint Symposium on Dendritic Cell Application in Solid Tumors in Combination with various forms of Hyperthermia” at the Delhi State Cancer Institute, Delhi, India, December 22^nd, 2012.

247. Appilcation of Dendritic cells in Solid Tumors” at the MAX Hospital Saket, New Delhi, India, December 26^th, 2012.

248. “Application of Dendritic Cells in Solid Tumors: a Novel Approach in Cancer Reseach and Therapy” at the PIMS Punjab organized by the Punjab Institute of Medical Sciences, Jalandhar, Punjab, India, December 30^th, 2012.

249. “Promising New Non-Toxic Therapies in Current Oncology: Practical Examples and Clinical Outcome” at Seminar at Delhi State Cancer Institute (DSCI) Delhi, India, and in Collaboration with MD Anderson Medical Center Houston, TX, USA. March 7^th and 8^th, 2013.

250. “In recurrent Glioblastoma multiforme Stage IV 46% complete remission with Dendritic cells Vaccinations in Combination with Local Hyperthermia (Celsius 42+); an Observational Study” at Guru Ram Das Medical Center, Amritsar, Punjab, India, July 8^th, 2013.

251 “46% Complete Remission in Recurrent Glioblastoma multiforme Stage IV with Dendritic Cell Vaccinations in Combination with Local Hyperthermia” IVth Hyperthermie Symposium Cologne, Germany, September 13th & 14th, 2013.

252 “Promising Cell Therapies: Dendritic Cells in Oncology and Adult Stem Cells in Tissue Repair” University of Shimla, Medical School and School of Dendistry, Shimla, India, October 10^th, 2013.

253 “Dendritic Cell in Combination with Hyperthermia and Mesenchymal Stem Cells in Tissue Repair” University of Malaysia (Universiti Sains Malaysia), Kelantan, Malaysia, January 4^th, 2014.

254 “Non-Toxic Cancer Treatment: the Gorter Model” University of Malaysia (Universiti Malaya) by the Department of Medical Biotechnology of the School of Medicine, Kuala Lumpur, Malaysia, January 6^th, 2014.

255 “Non-Toxic Cancer Treatment and Outcome: the Gorter Model,” Faculty of Biosciences and Medical Engeneering of the Universiti Teknologi Malaysia, Johor Bahru, Malaysia, January 7^th, 2014.

256 “Immunodeficiencies in Extreme Sports” Kahlsa University, Sports Medicine, Jalandhar, Ounjab, India, October 27^th, 2014.

256 “Bridge between Ayurvedic Medicine and the Gorter Model” at the Baba Masthnath University College of Ayurvedic Sciences” Rotakh, India, October 30^th, 2014.

257 “Development of proper sense perception in early age and its metamorphosis in older age into Mental and Spititual Qualities” University of Bologna, Bologna, Italy, January 15^th – 18^th, 2015.

258 “Clinical Outcome of Vaccinations with Naïve Autologous Dendritic Cells in Patients with Recurrent Glioblastome Multiforme in Combination with Electro-Capacitivce Hyperthermia (Celsius 42+)” International Forum for local Hyperthermia (Oncothermia). Barcelona, Spain, March 22nd & 23rd, 2015.

259 “Cell-Mediated Immunity and Hyperthermia in the Oncologic Patient” 23^rd S.R. Talwalkar Oration at the Lokmanya Tilak Municipal Medical College, Sion, Mumbai; October 12^th 2015.

260 “Non-Toxic Cancer Treatment in the 21^st Century” Keynote Speaker at a Public Conference for patients and their beloved ones. Municipal Library Mumbai; October 24^th, 2015.

261 “Hyperthermia and Viscum album in Oncology, and its DNA Repair Mechanisms” Saifee Hospital, Mumbai, October 25^th, 2015

262 “Il Doppio” at Stella Maris, Academy for Art Therapy in Bologna. January 15^th through 19^th, 2016.

263 City of Cologne Taskforce on Refugees from the Middle East, Afghanistan and Iran: “Cultural Sensitivities and taboos: an outline.” Cologne, Germany, February 20^th and March 5^th, 2016.

265 “Dendritic Cell Vaccinations in Combination with Hyperthermia and other Forms of Immune Restoration in the Oncologic Patient” Barmade Teaching Hospital, Latur, India, April 18^th, 2016.

266 “Innovative, Non-Invasive and Non-Toxic Cancer Treatments” SGT University Gurgaon, India, May 27^th, 2016.

267 Public Lecture: “Innovative, Non-Invasive and Non-Toxic Cancer Therapies” organized by the Combined Fraternity of Mumbai and Pune at the Freemason Hall in Mumbai, India. June 24^th, 2016.

268 Coordinated and sponsored by the University of Bologna, Department of Medicine, Italy, at the Scuola de Stelle Maris: “Etching as a Proven Effective Tool in the Recovery and Rehabilitation of Heroin Addicts and Alcoholics.” September 10^th-11^th-12^th 2016, Bologna, Italy.

267 Cancer Foundation of the State of Schleswig-Holstein, Germany; Brunsbüttel 8^th annual week on Cancer Awareness & Information 2016: “The Gorter Model and the Role of THC and CBD in Oncology.” November 1^st, 2016.

http://www.wattopedia.de/Krebsinformationstage_2016

268 ICARE: a Summit of Scientists, Health & Legal Eexperts and Researchers for a Dialogue about Phyto-Pharmaceutical Relevance of Medical Cannabis: Summit 2016. Delhi, Indian Habitat; October 29^th, 2016.

269 3rd International Conference on Industrial Hemp organized by the Indian Industrial Hemp Association (IIHA): “The medical Use of Cannabis and its Cannabinoids” Chambers of Commerce and Industry, Delhi, India, November 30^th, 2016. www.iihaindia.org

270 Fortis Hospital Chandigarh, Department of Oncology: “Dendritic Cell vaccinations in combination with hyperthermia in patients with solid tumors, like Glioblastoma multiforme.” Fortis Hospital, Chandigarh, India, March 22^nd, 2017.

271 Sophianum Medical Center, Budapest, Hungary and in collaboration with the “continuous medical education program” of the Semmelweiß University: “New Approaches in the Treatment of the Oncologic Patient anno 2017.” including a seminar on the medical use of Cannabonoids, with special focus on CBD.” November 28^th – December 4^th, 2017.

272 Second Affiliated Teaching Hospital of the Dalian University in Dalian, China (大连医科大学): “The Gorter Model in the Oncologic Patient.” December 27^th, 2017.

273 First Affiliated teaching Hospital of the Dalian University in China (大连医科大学): “The Gorter Model in the Oncologic Patient.” December 28^th, 2017.

274 First Affiliated teaching Hospital of Zhengzhou University in China (郑州大学) old building: “The Gorter Model in the Oncologic Patient.” December 29th, 2017.

275 First Affiliated teaching Hospital of Zhengzhou University in China (郑州大学) (new building): “The Gorter Model in the Oncologic Patient.” December 30th, 2017.

276 Sixteenth People’s Teaching Hospital of Zhengzhou University (郑州大学): “The Gorter Model in the Oncologic Patient.” December 31^st, 2017.

278 Liaocheng Cancer Hospital of the Liaocheng University(聊城大学): “The Gorter Model in the Oncologic Patient.” January 2^nd, 2018.

279 Central Teaching Hospital of Zibo, China: “The Gorter Model in the Oncologic Patient.” January 3^rd, 2018.

280 Tianjin Medical University Cancer Institute & Hospital: “The Gorter Model in the Oncologic Pattient.” January 4^th, 2018.

281 Stella Maris Academy for Art Therapy: “Il Doppio” January 19^th – 22^nd, 2018, Bologna, Italy.

282 Il Centro in Turino: “Dipendenze: sfida cruciale alla liberta dell’ Uomo.” March 17-19, 2018, Turino, Italy.

282 Government of Lebanon, Beirut, August 21^st – 24^th , 2018: Multiple sessions with the responsible authorities in Lebanon and the Chair of the Parliament and acting Head of State, Dr. Nabih Barri, on the decriminalization and legalization of Cannabis and its Cannabinoids. In addition, assist in setting up the cultivation of Cannabis and industrial hemp for medical applications and industrial use in Lebanon.

283 December 11^th through 19^th, 2018: Formal lectures to the Lebanese Parliament in full session on a proposal to change the law and fully decriminalize Cannabis for its medical and industrial use. Almost daily lecturing at the American-Lebanese University in Beirut on the Gorter Model; the medical use of Cannabis and its cannabiboids, and preparing clinical trials in various disease entities.

284 “The Clinical Application of various Cannabinoids: an Update.” University of Bologna, Italy, January 18^th through 21^st, 2019.

285 “The Clinical Application of Cannabis and its Cannabinoids” University of Turino in collaboration with a Patient Support Group. March 18-21, 2018.

286 The synergistic effects of Viscum album and Cannabidiol (CDB) and Tetra-Hydro-Cannabinol (THC) on improving significantly NK-cell activity and therefore survival in cancer patients. University of Milano Medical School, Grand Rounds, June 3-5th, 2019.

288 Synergistic Effects of Immunotherapies and Hyperthermia in Oncology: Yantai Qishan Teaching Hospital (President Zhiqiang Zou) October 13^th, 2019.

289 Synergistic Effects of Immunotherapies and Hyperthermia in Oncology: University hosptals at Weihai City Chinese Medical Hospital (President Shengcai Lan) and at the same day at Rushan People’s Hospital (President Xizhuo Ma); October 14^th, 2019.

290 The Gorter Model; Shenzhen Luohu People’s Hospital (President Xizhuo Sun); Ocober 16^th, 2019.

291 The Gorter Model and the Research and Use of Cannabinoids (since 1985); Shanghai East Hospital (Prof. Dr.Jin Li). October 17^th, 2019.

292 The practical applications and needed equipment to apply the Gorter Model; Shanghai Artemed Hospital (Dr. Willam Peng); October 18^th, 2019.

293 “How to become aware of subconscious impulses through art therapy”; Stella Maris Bologna, Italy, January 24-27, 2020.

294 Three-week 3 Units seminar on the Gorter Model with an emphasis on immune restoration at San Francisco State University (SFSU) from February 17^th through March 6^th, 2020. Several international quest speakers explained important components of its overall approach. Prof. Elior Kinathy from Vancouver presented his new book “I did it my way!” which he wrote from the point of view of a patient with end-stage prostate cancer who went through the “Gorter Model Treatment Protocol” treatment and once from a scientific point of view.

295 “Gene-based Vaccines by Retrovirusses as Vectors (Wheelbarrels): a Pandora’s Box?” Speaker at Seminar organized by University of Rotterdam in collaboration with Dutch Medical Association, Rotterdam, October 31st, 2020

296 Due to COVID-19 lockdowns, instead of on campus courses, series of multiple bi-weekly online lectures for students of San Francisco State Universty (SFSU) on Anthroposophic Health Studies (fall 2020 through fall 2022), immunology and virology; oncology and circadian rhythm; DNA repair and Dendritic Cells.

297 Weekend Seminar University of Bologna, Italy, in collaboration with Stella Maris Academy for Art Therapy (May 20 – 23, 2022).

298 At San Francisco State University, official 3-Unit course HH650 on Anthroposophic Health Studies (February 3^rd – April 18^th, 2023)

299 Weekend Seminar University of Bologna, Italy, in collaboration with Stella Maris Academy for Art Therapy (April 14th – 17th, 2023).

300 Weekend Seminar Rudolf Steiner Clinic The Hague, The Netherlands, on various practical aspects in Oncology and its basic research, including the application of autologous, monocyte-derived dendritic cells (May 20&21, 2023).

301 2-Days seminar on the Gorter Model, University of Leyden, The Netherlands, (May 3th-5^th, 2023.

302 One hour television presentation on “the Gorter Model” for Beyaz TV channel in Istanbul, Turkey, on September 13^th, 2023. Beyaz TV is a major TV Channel with millions of viewers in Turkey but also approximately 2 million viewers in Europe and Australia.

303 Official, three-weeks seminar on Anthroposophic Medicine at San Francisco State University October 1^st through 20^th, 2023.

304 Weekend Seminar on mRNA injectables: several aspects on the effects of mRNA as an enzyme that does gene-manipulation as its main effect: injected people are no longer defined as “Humans” but as “Human Tissue” (US Supreme Court 2013). University of Leyden (January 19^th-21^st, 2024).

305 From March 1^st, 2022 on, numerous lectures in public and online for Medical doctors and nursing staff, as well as for Universities in the USA and Europe and the Middle East, on the immune system in relation to mRNA-technology-based vaccinations, their consequent genmanipulation and immunosuppression (turbo cancer)

306 On March 9^th, One Day Seminar at the Dutch International “Vreede Huis” in The Hague, The Netherlands

307 Second One-Day Seminar for the Dutch “Alert Foundation” on all consequnces of mRNA and graphene hydroxide on September 14^th, 2024 in Bergen, The Netherlands.

Publications

Books:

Robert W. Gorter, MD: “ISCADOR, mistletoe preparations used in Anthroposophically extended cancer treatment.” Verlag für Ganzheitsmedizin, 1998. (published in 4 languages)

Robert Gorter Martin Straube: AIDS- Sprechstunde. Ein medizinisch-therapeutischer Ratgeber. Publ: Urachhaus (1996) in German (1996) ISBN-10: 3825170608; ISBN-13: 978-3825170608

Robert Gorter, MD, PhD and Erik Peper, PhD: “Fighting Cancer” a Non-Toxic Approach in Cancer Therapy, Publ: North Atlantic, Berkeley, California USA. April 2011. (is being translated and published in 16 other languages, including Mandarin Chinese and Arabic).

Robert Gorter, MD, PhD, Erik Peper, PhD: “Ik heb kanker: wat nu?” -nieuwe niet-toxische therapieen- Publ: Ankh-Hermes, Utrecht, Netherlands, September 2011. ISBN: 978902020553.

Robert Gorter, MD, PhD, and Erik Peper, PhD: “Kanseri nasil Yenerim” –Tedaviye Gertirilen Toksik Olmayan Bir Yaklasim Nobel Ödüllü Yeni Yöntem- Publ: Anadolu, Turkey, January 2012. Siparis No: A5080.

Robert Gorter, MD, PhD, Erik Peper, PhD: „Ich habe Krebs: was nun?” -Ein Ratgeber zu nicht-toxischen Behandlungsmöglichkeiten. – Publ: Anadolu, Germany, April 2012. ISBN: 978161215073.

Robert Gorter, MD, PhD and Erik Peper, PhD: “Il modello Gorter – Un’innovativa terapia atossica per il cancro”, Publ: Edizioni Polistampa, Florence, Italy. December 2012. ISBN: 9788859611639

Robert Gorter, MD, PhD and Erik Peper, PhD: “Am cancer. Si acum ce fac?”, Publ: Casa Cartii de Stiinta, Cluj-Napoca, Romania. December 2012. April 2012. ISBN: 978-606-17-0171-1

Robert Gorter, MD, PhD and Erik Peper PhD: Fighting Cancer in Mandarin Chinese (ca. 3.000.000 copies sold in Mainland China) and in Arabic (180.000 copies sold).

Robert Gorter in Italian and five books published by Associazione Amici della Scuola Steineriana in Milan, Italy:

1. DalleToxicodipendenzealle piccole dipendenze quotidiane
   

https://www.rudolfsteiner.it/shop/libri/crisi-biografiche/dalle-tossicodipendenze-alle-piccole-dipendenze-quotidiane

1. I quatro sacrifici del cristo
   
2. I dodici sensi dell’uomo
   

4&5) La biografia umana parte 1&2

Original Articles

Gorter R., “Een visie vanuit de antroposofie op ‘slecht slapen’ (Insomnia from an Anthroposophic Point of View)”, Tijdschrift voor Alcohol, Drugs en Andere Psychotrope Stoffen, The Royal General Foundation for the Treatment of Abuse in Alcohol and Drugs, the Hague, t.alc.drugs (8) 4, 1982

Abrams D., Kuno S., Wong R., Jeffords K., Nash M., Molaghan J., Gorter R., Ueno R., Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Ann Intern Med 110:3, 1989

Hersh EM., Brewton G., Abrams D., Bartlett J., Gorter R., et al. Ditiocarb Sodium (Diethyldithiocarbamate) Therapy in Patients with Symptomatic HIV infection and AIDS. JAMA 265 (12):1538-1544, 1991

Gorter RW., Management of anorexia-cachexia associated with cancer and HIV infection. Oncology 5(9):13-17, 1991

5. Plasse TF., Gorter RW, Krasnow SH, et al. Recent clinical experience with dronabinol. Pharmacol Biochem Behav; 40. 695-700, 1991

6. Gorter RW., Seefried M., Volberding P., Dronabinol effects on weight in
patients with HIV infection. AIDS 6:127-128, 1992

7. Slome L., Moulton J., Gorter R., Abrams D., Physicians’ attitudes toward
assisted suicide in AIDS. AIDS 5:712-718, 1992

8. Gorter R., Vranizan K., Osmond D., Moss AR. Differences in laboratory
values in HIV infection by sex, race and risk group. AIDS 6:1341-1347, 1992

9. Moss AR., Vranizan K., Gorter R., Bacchetti P., Osmond D., HIV seroconversion in intravenous drug users in San Francisco, 1985 – 1990, AIDS 8: 223-231, 1994

10. Zolopa AR.; Hahn A.; Gorter R.; Miranda J.; Wlodarczyk D.; Moss AR., HIV and Tuberculosis Infection in San Francisco’s Homeless Adults. JAMA; 272: 455-461, 1994

1. Mainka C., Wolff MH., Gorter R.; Vergleichende Untersuchung zum Nachweis von HIV-1-p24-Antigen mittels Enzymimmunoassay mit und ohne Immunkomplex-Dissoziation in Seren HIV-positiver Probanden. (Comperative examination to determine HIV-1-p24-antigen by means of enzyme immunoassay, with and without dissociation of antigen-antibody complex in sera of HIV-positive test subjects). Lab med 18: 508-511, 1994
   
2. Plasse, T.F.; Gorter, R.W.; Krasnow, S.H.; Lane, M.; Shepard, K.V.; Wadleigh, R.G. Recent clinical experience with dronabinol. Pharmacol. Biochem. Behav. 1991, 40, 695-700. …
   
3. Immune Deficiency Syndromes 25 (1), pp. 63–70. Moss, A. R., Vranizan, K., Gorter, R., et al. (1994), ‘HIV seroconversion in intravenous drug users in San Francisco, 1985–1990’, AIDS 8 (2), pp. 223–31. MSIC Evaluation Committee (2003), Final report of the evaluation of the S…
   
4. Food Technol. Biotechnol. 2005, 47, 210-214. Gordon, M.; Bihari, B.; Goosby, E.; Gorter, R.; Greco, M.; Guralnik, M.; Mimura, T.; Rudinicki, V.; Wong, R.; Kaneko, Y. A placebo controlled Nephroprotective Effect of Pleurotus ostreatus and Agaricus bisporus Extracts and Carvedilol on Ethylene Glycol-Induced Urolithiasis: Roles of NF-κB, p53, Bcl-2, Bax and Bak
   
5. Moss, A.R., Vranizan, K., Gorter, R., Bacchetti, P., Watters, J., & Os- mond, D. (1994). HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS , 8 , 223-231.
   
6. Gorter R., Stein J., Stoss M., Linder M.; Prospektive, longitudinale, dosis-eskalierende, randomisierte Phase I/II Studie mit Iscador^® QuFrF und Iscador^® Qu Spezial mit HIV-Positiven, Krebspatienten und gesunden, nichtrauchenden Probanden. Forsch Komplementärmed 3: 169-175, 1996
   
7. M. Stoss, E. Peter, M. Schnelle, M. Werner, R.W. Gorter, Viscum album QuFrF in HIV-positives and AIDS patients. 12^th World AIDS Conference, Geneva , Switzerland, 1998.
   
8. Gorter, R.W., Stoss M., Wollina W., Subcutaneous infiltrates induced by injection of mistletoe extracts (Iscador). Am. J. Therapeutics, 5; 181 – 187, 1998.
   
9. Stoss M., Gorter R.W., No evidence of IFN-y increase in the serum of HIV-positive and healthy subjects after subcutaneous injection of a non-fermented Viscum album L. extract. Natural Immunity; 16; 157-164. 1998.
   
10. Gorter, RW, Stoss M, Wollina W., Jollere P., Reif, M.: Cytokine release of EpiDermTM after incubation with IQuS and VaQuFrF (Iscador) Am. J. Therapeutics 6; 221-224, 1998.
    
11. Stoss M., Peter E., Gorter R. W., Decrease of activated lymphocytes four and nine hours after a subcutaneous injection of a Viscum album L. extract in healthy volunteers. Nat Immun 16 (5-6): 185-197, 1998.
    
12. van Wely, M., Stoss M., Gorter R.W., Toxicity of a standardized mistletoe extract in immunocompromized and in healthy individuals, Am. J. Therapeutics; 6 (1): 37 – 43, 1999.
    
13. Stoss M., van Wely M., Musielsky H., Gorter R.W., Study on Local Inflammatory Reactions and other Parameters during Subcutaneous Mistletoe Application in HIV-positive Patients and HIV-negative Subjects over a Period of 18 Weeks. Arzneim. Forsch./Drug Res. 49 (I), Nr. 4, 366 – 373, 1999.
    
14. Stoss M., Peter E., Gorter R.W., Decrease of activated lymphocytes 4 hours respective 9 hours after a subcutaneous injection of a Viscum album L.-extract in healthy volunteers. Natural Immunity 1998; 16:185-197.
    
15. Robert W. Gorter, MD, PhD, Madelon van Wely MS, Marcus Reif, PhD, Matthias Stoss, MD.: Tolerability of a Standardized, Non-Fermented Aqueous Viscum album L. Extract in Immunocompromised and Healthy Individuals: Alternative Therapies 1999; Vol. 5, Nr. 6, 37-48.
    
16. R. W. Gorter, Cancer Cachexia and Cannabinoids; Forsch Komplementärmed 1999; 6: 21-22.
    
17. M. Schnelle, F. Grotenhermen, M. Reif, R. W. Gorter; Ergebnisse einer standardisierten Umfrage zur medizinischen Verwendung von Cannabis-Produkten im deutschen Sprachraum. Forsch Komplementärmed 1999; 6: 28-36.
    
18. W. Stuecker, AS Bihari, RW Gorter; Ozontherapie zur Immunmodulation bei HIV-Infektion. AKODH 2000; 6: 74-82 (ISSN 1435-0327).
    
19. Stoss M., Michels M., Peter E., Beutke R., Gorter RW; Prospective cohort trial of Euphrasia single-dose eye drops in conjunctivitis. J Altern Complement Med 2000 Dec; 6(6): 499-508.
    
20. Killestein J, Hoogervorst ELJ, Reif M, Lalkers NF, van Loenen AC, Staats PGM, Gorter RW, Uitdehaag BMJ, Polman CH: Safety, tolerability, and efficacy of orally administered cannabinoids in MS. Neurology 2002;58:1404-1407.
    
21. Gorter RW, Joller P, Stoss M: Cytokine Release of a Keratinocyte Model after Incubation with two different Viscum album L. Extracts. Am J Ther 2003; 10:40-47.
    
22. Robert W. Gorter, Mario Butorac, Eloy Pulido Cobian, Ulrich Meyer: Anwendungsbeobachtung WALA Euphrasia Augentropfen. Der Merkurstab 2004;57 (2): 135-138.
    
23. R.W. Gorter: Erfahrungen mit Dronabinol (Tetrahydrocannbinol) bei onkologischen Patienten mit Anorexie-Kachexie-Syndrom. Der Schmerz 2004; Vol 18;suppl 2: 31-33.
    
24. Gorter, Robert W., Butorac, Mario, Cobian, Eloy Pulido: Examination of the Cutaneous Absorption of Copper After the Use of Copper-Containing Ointments. American Journal of Therapeutics: 11(6): 453-458, November/December 2004.
    
25. Gorter, Robert W., Butorac, Mario, Cobian, Eloy Pulido: Cutaneous Resorption of Lead After External Use of Lead-Containing Ointments in Volunteers with Healthy Skin. American Journal of Therapeutics 12(1): 17-21, January/February 2005.
    
26. Robert W. Gorter, MD, PhD; Mario Butorac, MA; Eloy Pulido, MD; Willem van der Sluis, PhD: Medical use of Cannabis in the Netherlands. Neurology: Mar 8, 2005;64 (5): 917-919.
    
27. R. W. Gorter, Freeman, Hammen, Murtomaa, A. Blinkhorn and G. Humphris: Psychological stress and health in undergraduate dental students: fifth year outcomes compared with first year baseline results from five European dental schools. European Journal of Dental Education; Volume 12, Issue 2, pages 61–68, May 2008.
    
28. Robert Gorter and Erik Peper: Treating Prostate Cancer with Immune Therapy Using the. “Gorter Model” in: Townsend Letter-The Examiner of Alternative Medicine, 329, 44-49.
    
29. Robert W. Gorter, Eloy Pulido, Daniela Hudi, Eva-Maria Turnwald: “Anthroposophically-Extended Medicine” Jana Council for Scientific Development (JCSD) and the Kadota Fund International Forum 2011 Kyoto, Japan. February 12^th – 14^th, 2011; also in Abstract Book:16-17.
    
30. Robert Gorter, MD, PhD: Townsend Letters: “Underappreciated Risks in Pain Management” November 2018.
    
31. Robert Gorter, MD, PhD: Townsend Letters: Cannabis in Pain Management” November 2018.
    
32. Zolopa AR, Hahn JA, Gorter R, Miranda J, Wlodarczyk D, Peterson J, et al. HIV and tuberculosis infection in San Francisco’s homeless adults. Prevalence and risk factors in a representative sample. JAMA 10;272(6):455-461.
    
33. Zolopa AR, Hahn JA, Gorter R, Miranda J, Wlodarczyk D, Peterson J, et al. HIV and tuberculosis infection in San Francisco’s homeless adults: prevalence and risk factors in a representative sample. JAMA. 1994;272(6):455-61. Burt MR. Helping America’s homeless: emergency shelter or affordable hou…
    
34. Moss, A. R., Vranizan, K., Gorter, R., Bacchetti, P., Watters, J., Osmond, D. (1994), ‘HIV seroconversion in intravenous drug users in San Francisco, 1985–1990. AIDS 8: 223–31.
    
35. Zolopa AR, Hahn JA, Gorter R, et al. HIV and tuberculosis infection in San Francisco’s homeless adults: prevalence and risk factors in a representative sample. JAMA. 1994;272(6):455-61.
    
36. Gorter RW, van Wely M, Reif M, Stoss M. Tolerability of an extract of European mistletoe among immunocompromised and healthy individuals. Altern Ther Health Med 1999;5:37-44 and 47-48.
    
37. Gorter, RW, van Wely: Glucose lowering effect of leaf extracts of Viscum Album in normal and diabetic rats Altern Ther Health Med 1999;5:37-44 and 47-48.
    
38. Only through metamorphosis human being can grow and become complete https://docs.google.com/file/d/19OZe6U72Wtt8h-7icyf1aoNYQSJuIEkb/edit?usp=docslist_api&filetype=msword
    
39. New paradigms and Understanding of how Spinal Cord
    

Stimulation can improve psychological Disorders on the long term

https://docs.google.com/file/d/1aWXbfEhxwQSuDA59eE96b_IwsElQtHdH/edit?usp=docslist_api&filetype=msword

1. Gorter, RWD and Dany Ghassan; Art therapy and psychotherapy.https://docs.google.com/file/d/173oCUkP1AGQeZxWShXA1waje7ogsQu8N/edit?usp=docslist_api&filetype=msword
   
2. Gorter, RWD and Dany Ghassan: Victimization, difference between true victim and false victim
   

https://docs.google.com/file/d/1qAIpqk6Jqbm1wImLspP_cHWBV-xSjoFz/edit?usp=docslist_api&filetype=msword

1. Gorter,RWD and Dany Ghassan: Common Disorders among Children when going to School for the very first Time or Returning to School
   

https://docs.google.com/file/d/1zwP6tql2UzEdOJnnwuPJcIFfoZI1_LQW/edit?usp=docslist_api&filetype=msword

1. Gorter, RWD , Dany Ghassan Self Control and how Strengthen and Envisioned that. https://www.facebook.com/shar/p/ztS871zrNnXUfa8N/?mibextid=xfxF2i
   
2. Gorter, RWD , Dany Ghassan https://docs.google.com/file/d/1yqFn_lI7MGjkP7cL3p04Jb2AMwsMf1up/edit?usp=docslist_api&filetype=msword
   
3. Gorter, RWD , Dany Ghassan https://docs.google.com/file/d/19vJD99BdFel0DNuYy7cUCkfbWNfvywd2/edit?usp=docslist_api&filetype=msword
   
4. Gorter, RWD , Dany Ghassan https://docs.google.com/file/d/15vT9Ut4dI9eOfAKhUZI-lKc51wWzE2Hk/edit?usp=docslist_api&filetype=msword
   
5. Gorter, RWD , Dany Ghassan https://www.facebook.com/share/p/BSTkkmJGLJ1qocCJ/?mibextid=WC7FNe
   
6. Gorter, RWD , Dany Ghassan https://docs.google.com/file/d/19OZe6U72Wtt8h-7icyf1aoNYQSJuIEkb/edit?usp=docslist_api&filetype=msword
   
7. Gorter, RWD , Dany Ghassan https://docs.google.com/file/d/19OZe6U72Wtt8h-7icyf1aoNYQSJuIEkb/edit?usp=docslist_api&filetype=msword
   
8. Gorter, RWD , Dany Ghassan https://docs.google.com/file/d/1aWXbfEhxwQSuDA59eE96b_IwsElQtHdH/edit?usp=docslist_api&filetype=msword
   
9. Gorter, RWD , Dany Ghassan https://docs.google.com/file/d/173oCUkP1AGQeZxWShXA1waje7ogsQu8N/edit?usp=docslist_api&filetype=msword
   
10. Gorter, RWD , Dany Ghassan https://docs.google.com/file/d/1qAIpqk6Jqbm1wImLspP_cHWBV-xSjoFz/edit?usp=docslist_api&filetype=msword
    
11. Gorter, RWD , Dany Ghassan https://docs.google.com/file/d/1zwP6tql2UzEdOJnnwuPJcIFfoZI1_LQW/edit?usp=docslist_api&filetype=msword
    

63. Gorter, RWD , Dany Ghassan; Thinking feeling and willing, and their reflections in three fold social order. https://docs.google.com/file/d/1yqFn_lI7MGjkP7cL3p04Jb2AMwsMf1up/edit?usp=docslist_api&filetype=msword

1. Gorter, RWD , Dany Ghassan; Positive stress /negative stress , almost everything has two sides; https://docs.google.com/file/d/19vJD99BdFel0DNuYy7cUCkfbWNfvywd2/edit?usp=docslist_api&filetype=msword
   
2. Gorter, RWD , Dany Ghassan; Music and it’s major benefits in human sociall and religious life and in therapy https://docs.google.com/file/d/15vT9Ut4dI9eOfAKhUZI-lKc51wWzE2Hk/edit?usp=docslist_api&filetype=msword
   

First author in many scientific books:

1 Fighting cancer in a nontoxic way. Published in English and translated into 14 leading foreign languages In China, more than 3.000.000 copies were sold.

Book Chapters

1. Gorter R., Transmission of HIV in Intravenous Drug Users. San Francisco General Hospital AIDS Knowledge Base (computer data base). Philip T. Cohen, Merle A. Sande, Paul Volberding, eds. Waltham, MA: Massachusetts Medical Society, 1991.

2. Gorter R., Transmission of HIV in Intravenous Drug Users. In the AIDS Knowledge Base. Philip T. Cohen, Merle A. Sande, Paul Volberding, eds. Waltham, MA: Massachusetts Medical Society, 1991.

1. Gorter R., Cannabis: Schmerztherapie (noch) in der Illegalität. In Schmerz Praxis Ratgeber/ZDF Gesundheitsmagazin. J. Apfelbach (Hrsg.) Einhorn Presse Verlag 1996. ISBN 3-88756-800-1.
   
2. Robert Gorter, Erfahrungen mit Dronabinol (Delta 9 Tetrahydrocannabinol) bei onkologischen Patienten mit Anorexie-Kachexie-Syndrom in Der Schmerz (Dezember 2004) 18(suppl.2); S31-S33. Springer Verlag.
   
3. Robert Gorter, Mehr Lebensqualität für Patienten in ultimativen Situationen. In: 1. Colloquium Dronabinol-Therapie 2003. Delta-9-Pharma.
   

Overview Articles

1. Gorter RW., Consciousness of the Newborn, Intermediair, Elsevier/Excerpta Medica, Amsterdam, 1974.
   
2. Gorter RW., Bos TW. Acupuncture – a real treatment for addicts? The Royal General Foundation for the Treatment of Abuse in Alcohol and Drugs, The Hague, 1977.
   
3. Gorter RW., Violations of human rights: torture and the medical profession. Medisch Contact, The Royal Dutch Medical Association, Utrecht, June, 1978.
   
4. Robert Gorter., Management of Anorexia-Cachexia in Advanced HIV Disease. Clinical Notes, PAACNOTES , volume 3, number 5, 1991.
   
5. Gorter RW., Experience with viscum album (Iscador) and Marihuana (Dronabinol) in: AIDS, eine Krankheit wird behandelbar; Materialien zur HIV-Erkrankung im 2. Jahrzehnt, Ecomed, Band III, p 167 – 171, 1993
   
6. Gorter RW., Medikamentöse Beeinflußung von Stoffwechsel und Appetit, in: HIV-Medizin: Möglichkeiten der individualisierten Therapie. Wissenschaft-liche Ergebnisse in der mitte der 90er Jahre. Jäger (Hrsg.), Ecomed, Band IV, p. 233 – 238, 1994
   
7. Robert Gorter; I Dodici Sensi Dell’Homo, febbraio 1995, Assoziatione Amici della Scuola Steineriana, via Clevicetti 45, Milano, Italia
   
8. Gorter RW., Management of Anorexia-Cachexia Associated With Cancer and HIV-Infection, International Conference on Bioresource Hemp, Frankfurt, Germany, March 1995, Proceedings Vol. I
   
9. Gorter RW., el Arif N, Stoss M: Anthroposophische Medizin. In:
   
   
   Wolfstädter HD; Unkonventionelle Medizin bei HIV und AIDS. Hrsg.
   
   
   Deutsche AIDS-Hilfe e.V. Berlin, 1995.
   
10. Robert Gorter, La Biografia Umana. Settembre 1996, Assoziatione Amici della Scuola Steineriana, via Clevicetti 45, Milano, Italia.
    
11. Baumann E, Mandera R, Schnelle M, Zeh K, Stoss M, Gorter RW; Cannabis als Heilpflanze. Der Merkurstab, 1997, 50 (2), p. 94 – 103.
    
12. Grotenhermen F, Gorter RW: Cannabis und Psychosen. Der Merkurstab, (4) 231 – 237, 1997
    
13. Gorter, RW, Stoss M., Moderne Misteltherapie, Privatärztliche Praxis, 02 (4); p. 186 – 188,1997.
    
14. Gorter, Robert W, Cannabis bei Anorexie und Kachexie von Krebs- und AIDS-Patienten In: Cannabis und Cannabinoide als Medizin, ISBN 3-9805840-4-6, 1997
    
15. Robert Gorter; La Biografia Umana Parte I & II, settembre 1997/novembre 1998, Associazione Amici della Scuola Steineriana, via Clericetti 45, Milano, Italia
    
16. Gorter RW, Cannabis und chronische Schmerzen. In: Abstractband Der
    Deutsche Schmerztag 1998; 9. Deutscher interdisziplinärer Schmerzkongreß. p.26 – 28, Frankfurt am Main 4. – 8. März 1998.
    
17. Gorter RW, Stoss M; Immunmodulation und Krebstherapie. Moderne Misteltherapie. Privatärztliche Praxis 1998, 2(6), p. 186 – 188
    
18. Stoss M, Gorter RW; Moderne Misteltherapie in der Onkologie. Pharmazeu-tische Rundschau. 1998, 8, p. 32-34
    
19. Stoss M, Robert W. Gorter; Die Iscador-Therapie in der Onkologie. Schweizerische Zeitschrift für GanzheitsMedizin, Jg. 11, Heft 2, März 1999, p 91-95.
    
20. Robert Gorter, I Sacrifici del Cristo, il Loro Significato per l’Evoluzione Umana e la Loro Ricapitolazione nel Perdono. Novembre 1998, Associazione Amici della Scuola Steineriana, via Clericetti 45, Milano, Italia.
    
21. Gorter R. Karnow G, Stoss M; Anthroposophical Medicine-Comprehensive Cancer Care. Center for Mind-Body Medicine, transcripts II, June 12^th, 1999, Washington DC, USA
    
22. Wilfried Stücker, Robert W. Gorter, Dagmar Marx; Dendritische Zellen in der Tumortherapie. Naturheilpraxis Jg.56, Heft 3: 408-411, März 2003.
    
23. Robert Gorter, Erfahrungen mit Dronabinol (Delta 9 Tetrahydrocannabinol) bei onkologischen Patienten mit Anorexie-Kachexie-Syndrom in Der Schmerz (Dezember 2004) 18(suppl.2); S31-S33. Springer Verlag.
    
24. Robert W. Gorter: O cancro e uma doenca do Sistema Imunitario in Noticias Medicas Nr. 3001, September 10^th, 2008. (O Jornal da Medicina Portuguesa).
    

Abstracts & Oral Presentations

1. Brodie B., Gorter R., Chaisson RE., Moss AR., Volberding PA., Clinical care of IV drug users (IVDUs) with HIV infection. Program & Abstracts IVth International Conference on AIDS, June 12-16, 1988, Stockholm, Sweden, #8509.
   
2. Kocurek D., Bacchetti P., Gorter R., Moss A., HIV seropositivity in IVDU Vietnam combat veterans. Vth International Conference on AIDS, Montreal A525, page 165, June, 1989.
   
3. Moss A., Bacchetti P., Osmond D., Meakin R., Keffelew A., Gorter R., Seroconversion for HIV in intravenous drugs users in San Francisco. VIth International Conference on AIDS, Montreal, Th. A. P. 102, page 157, June,1989.
   
4. Gorter R., Kocurek K., Brodie B., Bacchetti P., Ross E., Moss A., Progression of HIV disease in intravenous drug users. Vth International Conference on AIDS, Montreal, T.A.O. 11 page 56, June, 1989.
   
5. Vranizan K., Gorter R., Osmond D., et al., Laboratory markers for HIV in intravenous drugusers in San Francisco: Race and sex differences. VIth International Conference on AIDS, San Francisco, California, June, 1990 F.C. 554 Abstract Book Vol. II p. 219.
   
6. Moss A., Vranizan K., Bacchetti P., Gorter R., et al., Seroconversion for HIV in intravenous drug users in treatment, San Francisco 1985-1990. VIth International Conference on AIDS, San Francisco, California, June, 1990. F.C. 553 Abstract Book Vol II p. 219.
   
7. Keffelew A., Clark G., Bacchetti P., Gorter R., et al., Use of needle exhange programs by San Francisco drug users in methadone treatment. VIth International Conference on AIDS, San Francisco, California, June, 1990. F.C. 107 Abstract Book Vol II p. 116.
   
8. Goldstein A,, Gavojdea S,, Gorter R., et al., Analysis of HIV antibodies in serum versus whole saliva. VIth International Conference on AIDS, San Francisco, California, June, 1990. S/C/613 Abstract Book Vol I p 272.
   
9. Wolfe H., Vranizan K., Gorter R., et al., Crack use and related risk factors in IVDUs in San Francisco. VIth International Conference on AIDS, San Francisco, California, June, 1990. Th.C. 591 Abstract Book Vol I p 273.
   
10. Gorter R., Vranizan K., Moss A., et al., Progression of HIV disease in intravenous drug users. VIth International Conference on AIDS, San Francisco, California, June, 1990. Th.C. 664 Abstract Book Vol I p. 286.
    
11. Slome L., Moulton J., Huffine C., Gorter R., et al., Physician’s attitudes toward assisted suicide in AIDS. VIth International Conference on AIDS, San Francisco, California, June 1990.
    
12. Abrams D., Greco M., Wong R., Goosby E., Gorter R., et al., Results of a phase I/II placebo-controlled dose finding pilot study of lentinan in patients with HIV infection. VIth International Conference on AIDS, San Francisco, California, San Francisco, June 1990. S.B.487 Abstract Book Vol III p 207
    
13. Williams A., Vranizan K., Gorter R., et al., Methadone maintenance, HIV serostatus and race in injection drug users (IDU) in San Francisco, CA. VIth International Conference on AIDS San Francisco, California, June 1990. S.C. 748 Abstract Book Vol III p 276.
    
14. Gorter R., Osmond D., Galli D., Hanson C., Vranizan K., Moss A., Co-infection of HIV-1 and HTLV-I/II on intravenous drug users in treatment programs in San Francisco. VIIth International Conference on AIDS, Florence, Italy, June 1991. M.C. 2372, p 366 Abstract Book Vol I.
    
15. Wolfe H., Hannah, Zolopa A., Kefflew A., Meakin R., Gorter R., Miranda J., Psychiatric disorder and HIV infection among San Francisco Homeless. VIIth International Conference on AIDS Florence, Italy, June 1991. W.D. 4043, p. 398 Abstract Book Vol II.
    
16. Zolopa A., Gorter R., Meakin R., Kefflew A., Wolfe H., Moss A., Homelessness and HIV infection: a population based study. VIIth International Conference on AIDS, Florence, Italy, June 1991. M.C. 3244, p. 359, Abstract Book Vol I.
    
17. Plasse T., Connant M., Gorter R., Sheperd K., Dronabinol stimulates appetite and causes weight gain in HIV patients. VIIIth International Conference on AIDS, Amsterdam, Netherlands, July 1992. PuB 7442, p.122, Abstract Book.
    
18. Gorter R., Khwaja T., Linder M., Anti-HIV and immunomodulating activities of Viscum album (mistletoe). VIIIth International Conference on AIDS, Amsterdam, Netherlands, July 1992. PuB 7214, p.84, Abstract Book.
    
19. Tappero J., Gorter R., Fila D., Child C., Mitchell T., Alpha-interferron for severe HIV-associated molluscum contagiosum. VIIIth International Conference on AIDS, Amsterdam, Netherlands, July 1992, PoB 3886, p.238, Abstract Book.
    
20. Gorter R., Stoss M., El Arif N., Labonte B., Beckmann C., Anti-HIV and immunomodulating activities of Viscum album (Iscador®). IXth International Conference on AIDS, Berlin, Germany, June 1993. PO-B28-2167, p. 496, Abstract Book Vol. I.
    
21. Gorter R., Stoss M., Stein J., el Arif N., Immunomodulating and anti-HIV activities of Iscador. Scientific advances in complemantary medicine, Padova, Italy, June 1995
    
22. Gorter R., Double-blind, placebo controlled parallel study to document the effect of delta-9-THC on appetite and weight in symptomatic HIV-infection and AIDS. 5. Münchner AIDS-Tage, München, Germany, Jan. 1996. In: AIDS und HIV-Infektion in Klinik und Praxis: Vol. 5; 226 – 227
    
23. Gorter R., Bestimmung der Virusbelastung mittels branched-DNA bei HIV-Positiven mit Iscador QuFrF-Behandlung. 5. Münchner AIDS-Tage, München, Germany, Jan. 1996. In: AIDS und HIV-Infektion in Klinik und Praxis: Vol. 5; 228 – 229
    
24. Gorter RW., Stein J., Stoss M., Schuler C., Phase II study to document anti-HIV efficacy of Iscador QuFrF (Viscum album L.). First European Conference on Experimental AIDS Research. Abstract Book; 196 – PS6, Cannes, France, Jan. 1996
    
25. Heinzerling L., Rotty J., van Wely M., Portalupi E., Gorter R., Prospective Phase-III Studie zur Bestimmung der krebshemmenden und immun-modulierenden Wirkung von Iscador®-Qu Spezial bei Patientinnen mit Cervixdysplasie. Conference on Unconventional Medicine. BMFT, Abstract Book, p. 47, Bonn Germany, Dec. 1997
    
26. Gorter, RW., Cannabis sativa in der medizinischen Betreuung von Drogen- gebrauchern/innen. 6. Deutscher AIDS-Kongreß, Abstract Book; V156, p. 46, München, Germany, Oct. 1996
    
27. Gorter RW., Prospektive longitudinale Phase-III-Studie zur Bestimmung der präventiven und krebshemmenden Wirkung von Iscador Qu Spezial bei Patientinnen mit Cervixdysplasien. Bundesministerium für Forschung und Technik: Workshop „Unkonventionelle medizinische Richtungen und unkonventionelle Methoden der Krebsbekämpfung“, Bad Honnef am 23. und 24.
    Februar 1996. In: Forsch Komplementärmed (4) 58 – 68, 1997.
    
28. Gorter RW., Cannabis and HIV wasting. Third international conference on home and community care for persons living with HIV/AIDS, Abstract Book; O179, Amsterdam, May 1997
    
29. van Wely M., Stoss M., Gorter RW., Open Label phase-II trial to document immunomodulating and anti-HIV activities of Iscador QuFrF in HIV positives. Abstract book 190-P4. 2 nd European conference on Experimental AIDS Research Stockholm, Sweden, June, 1997
    
30. Gorter RW., Schnelle M., Stoss M., van Wely M; Cannabis and wasting in AIDS and cancer. International 1997 Symposium on the Cannabinoids, Abstract Book, p. 87, Atlanta, USA, June 1977
    
31. Schnelle M., Stoss M., van Wely M., Gorter RW.; Cannabis zur Behandlung von Anorexie / Kachexie bei AIDS-Patienten – Toxikologische Aspekte. In: Neue Perspektiven Therapeutische Erwartungen; Die Realität 1997; Monographienreihe Band 6, p. 232 – 236, München July 1977
    
32. van Wely M., Stoss M., Gorter RW.; Open-Label Phase-II-Studie zur Bestimmung der immunmodulierenden und antiviralen Wirkungen von Iscador QuFrF bei HIV-Positiven Patienten.. In: Neue Perspektiven Therapeutische Erwartungen; Die Realität 1997; Monographienreihe Band 6, p. 243 – 244, München July 1977
    
33. Gorter RW., Rotty J., Heinzerling L., Schnelle M.; The immunomodulating activities of Iscador Qu Spezial (Viscum album) in patients with HPV-associated cervical dysplasia. In: Abstract Book, First Polish Scientific Conference on Colposcopy and Cervix Dysplasia, p. 217. Zakopane, March 1998
    
34. Gorter, Robert W., Viscum album L. (aqueous extract) as an immunomodulator and antiviral drug in HIV. A phase II trial. 12^Th World AIDS Conference Geneva, Switzerland. 1998, Abstract 44323, Abstract Book
    
35. Robert Gorter, Matthias Stoss, Ellen Peter, Danyl Soto-Vera, Prospective, open-label Phase-II-Study to document the immunomodulatory and anti-HIV-activity of VaQuFrF in HIV-positives over 11 months. Eur J Med Res 4 (suppl 1); 10, 1999
    
36. I. Sanne, D. Spencer, R. Smego, R. Gorter, Immunomodulation of VaQuFrF as adjuvant therapy in combination with Zidovudine and Lamiduvine in HIV-therapy. Eur J Med Res 4 (suppl 1); 10, 1999
    
37. Robert W. Gorter, Matthias Stoss, Danyl Soto-Vera, No evidence of IFN-γ increase in the serum of HIV-positive and healthy subjects after subcutaneous injection of a non-fermented Viscum album L. extract. Eur J Med Res 4 (suppl 1); 58, 1999.
    
38. Robert W. Gorter, A whole-plant Cannabis extract for anorexia / cachexia in cancer patients. Yoint Meeting British and German Pharmacological Societies Nottingham, UK, July 1999, Abstractbook page 8.
    
39. Robert W. Gorter, An observational study with Medical Grade Marijuana (MGM) in the Netherlands, International Cannabinoid Research Society, Abstractbook, page 111, Baltimore, June 22^nd-24^th, 2000.
    
40. Robert W. Gorter, Possible anti-cancer and anti-retroviral activities of Sutherlandia. Abstract Book, page 45. 38^th annual meeting Drug Information Association, Chigaco, USA, June 16^th -21^st, 2002.
    
41. Gorter RW, Practical medical applications of Cannabis and Cannabinoids. Archiv der Pharmazie Vol. 335 (Suppl. 1) page 30, September 2002.
    
42. Killerstein J, Hoogervorst ECJ, Reif M, Kalkers NF, Van Loenen AC, Staats PGM, Gorter RW, Uitdehaad BMJ, Polman CM: Safety, tolerability and efficacy of orally administered cannabinoids in multiple sclerosis: a randomized, double-blind, placebo-controlled. Two-fold cross-over study. Multiple Sclerosis, Vol 7, suppl 1, September 2001 (platform presentation 0-35).
    
43. Matthes C, Marx D, Cillien C, Gorter R, Lorenzen D, Peters H, Nesselhut T: Marker expression of monocyte-derived dendritic cells in healthy individuals and cancer patients; correlation to clinical response. 39^th annual meeting of the American Society of Clinical Oncology, Proceedings of ASCO, page 180, #723, Chicago, May 31^st-June 4^th, 2003.
    
44. T Nesselhut, R Chang, C Matthes, D Marx, D Lorenzen, N Cillien, M Martin, R Gorter, J Peters: Cancer therapy with unloaded monocyte-derived dendritic cells in patients with inoperable pancreatic and gall bladder cancer. 40^th Annual meeting of the American Society of Clinical Oncology, proceedings of ASCO, page 180, #2569, New Orleans, USA, June 5^th-8^th, 2004.
    
45. Robert Gorter, Eloy Pulido, Mario Butorac: “Fever-Range, Total-Body Hyperthermia in Combination with Autologous Dendritic Cells in Cancer Patients” The Kadota Fund International Forum, Awaji Yumebutai International Congres, Awaji Islands, Hyogo, Japan, Abstract Book, page 41, #20, June 14^th -18^th, 2004.
    
46. Thomas Nesselhut, Constanze Matthes, Dagmar Marx, Raymond Chang, Dirk Lorenzen, Robert Gorter, Hinrich Peters: Cancer therapy with immature monocyte-derived dendritic cells in patients with advanced breast cancer. 41^st Annual Meeting of the American Society of Clinical Oncology, proceedings of ASCO, Orlando, USA, May 11^th – 15^th, 2005.
    
47. Robert W. Gorter, MD, PhD, et al, “Clinical Outcome of Vaccinations with Naïve (Non-Pulsed) Dendritic Cells in Patients with Recurrent Glioblastome Multiforme in Combination with Electro-Capacitive Hyperthermia (Celsius 42+)” Delhi State Cancer Institute, Delhi, India, page 23, December 22^nd & 23^rd, 2012.
    
48. Robert W. Gorter: 46% Complete Remission in Recurrent Glioblastoma multiforme Stage IV with autologous naïve Dendritic Cell Vaccinations in combination with Local Hyperthermia” Proceedings of the Vth International Hyperthermie Symposium Cologne, Germany, September 13th & 14th, 2013.
    
49. Currently, over 8,000 times, our scientific articles in leading medical and public health journals have been cited by others.
    
50. My book “Fighting Cancer” has been translated into 15 major languages and in Chinese, more than 3,000,000 copies were sold.
    

Series of articles conceived for the Pytagoras Foundation in Beirut, Lebanon (2024):

https://www.instagram.com/p/C8wslbBMeMI/?igsh=MWZ2anVpcHBkY2xuaQ==

https://www.facebook.com/share/p/BSTkkmJGLJ1qocCJ/?mibextid=WC7FNe

https://docs.google.com/file/d/19OZe6U72Wtt8h-7icyf1aoNYQSJuIEkb/edit?usp=docslist_api&filetype=msword

https://docs.google.com/file/d/19OZe6U72Wtt8h-7icyf1aoNYQSJuIEkb/edit?usp=docslist_api&filetype=msword

https://docs.google.com/file/d/1aWXbfEhxwQSuDA59eE96b_IwsElQtHdH/edit?usp=docslist_api&filetype=msword

https://docs.google.com/file/d/173oCUkP1AGQeZxWShXA1waje7ogsQu8N/edit?usp=docslist_api&filetype=msword

Video documentaries:

De Maretak is een heel bijzondere plant: